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Although they appeared to slow the rate of health care cost increases in the
1990s,1 the health plans that emerged in the marketplace in the managed care
era generally disappointed early supporters of the health care revolution.2  Most
of those reformers envisioned a future in which health maintenance
organizations (“HMOs”) and other hoped-for organizational innovations would
prove to be effective and desirable vehicles for generally improving the quality
of care and rationalizing health care spending.  A few theorists, however, took a
somewhat broader view, and hoped to see the entire health care system
transformed into a relatively unfettered competitive market in which spending
would reflect primarily the preferences of consumers, not the system’s own
imperatives.3  Reformers of the latter, more market-oriented kind were doomed
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1. Clark C. Havighurst, Is the Health Care Revolution Finished?—A Foreword, 65 LAW &
CONTEMP. PROBS. 1, 2 (Autumn 2002) (discussing cost trends during the era of managed care).
2. Gail Agrawal & Howard Veit, Back to the Future: The Managed Care Revolution,  65 LAW &
CONTEMP. PROBS. 11, 41 (Autumn 2002) (“The managed care industry . . . established its future sepa-
rate from the goals of early HMO pioneers and the vision of Paul Ellwood and other delivery system
reform advocates.”). For a discussion of the appropriateness of characterizing the last generation of
American health policy as revolutionary, see Havighurst, supra note 1.
3. The crucial difference between these more market-oriented reformers and early advocates of
organizational reform was the former’s lesser emphasis on reorganization as an end in itself and heavier
emphasis on creating a market process that would push industry actors toward efficient organization of
medical care and efficient levels of health care spending.  For early articles expressing the market
reformers’ vision, see James F. Blumstein & Michael Zubkoff, Perspectives on Government Policy in
the Health Sector, 51 MILBANK Q. 395 (1973) (discussing the rationale for government intervention in
the health sector, health care as a “merit good,” and competition as a policy strategy); James F. Blum-
stein & Frank A. Sloan, Redefining Government’s Role in Health Care: Is a Dose of Competition What
the Doctor Should Order?, 34 VAND. L. REV. 849 (1981) (describing and analyzing the market-oriented
approach and distinguishing among market advocates); Clark C. Havighurst & James F. Blumstein,
Coping with Quality/Cost Trade-offs in Medical Care: The Role of PSROs, 70 NW. U.L. REV. 6, 65
(1975) [hereinafter Havighurst & Blumstein, Coping] (questioning regulatory approach to cost-con-
tainment and predicting, “[i]f the health insurance market could be reconstituted to give consumers a
range of appropriate choices, some cost-conscious consumers would prefer lower-priced plans which
provide fewer and/or lower-quality services”); Clark C. Havighurst, Health Maintenance Organizations
and the Market for Health Services, 35 LAW & CONTEMP. PROBS. 716 (Autumn 1970); Clark C.
Havighurst et al., Strategies in Underwriting the Costs of Catastrophic Disease, 40 LAW & CONTEMP.
PROBS. 122, 188 (Autumn 1976) (questioning proposals for comprehensive national health plans on
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to face greater disappointment as the health care industry evolved.  This article
seeks to explain the failure of the health care revolution to achieve its most
ambitious goals, especially the more radical one of installing a truly democratic
regime based on competition and real consumer choice.4
Early reformers advocating principally organizational reform envisioned
health plans that would closely integrate the financing and delivery of care and
organize providers into discrete prepaid groups, each striving to compete not
just on price but, more importantly, by improving efficiency and the quality of
care.5  Their hopes for such integration were based in part on observing a few
ground that “political processes dominated by the medical profession and the lifesaving imperative are
poorly adapted to making choices with potentially tragic consequences”); Paul Starr, A National Health
Program: Organizing Diversity, HASTINGS CENTER REP., Feb. 1975, at 11, 13 (envisioning a system
that, “[r]ather than insisting on a uniform definition of the limits of health care, . . . encourage[s] a var-
ied set of programs in a community” and “preserves free choice and accommodates cultural diversity”);
see also ALAIN C. ENTHOVEN, THEORY AND PRACTICE OF MANAGED COMPETITION IN HEALTH
CARE FINANCE 9-10 (1988) (outlining a structured model of “managed” competition based on the
principle that “cost-conscious consumer choice is necessary to create incentives for people to develop
and demonstrate less costly alternative ways of organizing medical care of acceptable quality”); CLARK
C. HAVIGHURST, HEALTH CARE CHOICES: PRIVATE CONTRACTS AS INSTRUMENTS OF HEALTH
REFORM (1995) [hereinafter HAVIGHURST, HEALTH CARE CHOICES] (arguing that private contracts,
rather than regulatory and legal standards, can and should govern patient entitlements and provider
and health plan obligations); Einer Elhauge, Allocating Health Care Morally, 82 CAL. L. REV. 1449,
1456 (1994) (outlining health system with voucher-like, risk-adjusted government contributions to
competing health plans, “allowing individuals to sign up with the care-allocating plan that offers the
health maximization policy they most prefer”); Arti K. Rai, Rationing Through Choice: A New
Approach to Cost-Effectiveness Analysis in Health Care, 72 IND. L.J. 1015, 1018 (1997) (“Choice is
desirable for the following reasons: first, moral theory does not provide a determinate answer to the
question of how we should ration care; second, the most commonly prescribed alternative to moral
theory—the democratic political process—does not respect the diversity of individual health and alloca-
tional preferences . . . ; and third, choice can be implemented in a manner that not only respects indi-
vidual autonomy but also attends to other important moral principles, such as justice and
beneficence.”).
Inevitably, the analysts cited above differ among themselves on important issues.  (For example,
Enthoven has endorsed substantial standardization of health coverage to facilitate price comparisons,
ENTHOVEN, supra, at 104-05, whereas my book envisions product differentiation allowing consumers to
choose between explicitly different levels of quality, especially with respect to generosity in covering
services of only arguable net benefit in a cost/benefit comparison.)  The common threads through all,
however, are heavy reliance on competition and cost-conscious consumer choice and acceptance of
some measure of inequality, though with substantial public subsidies to ensure a decent minimum level
of care for all.  See id. at 8 (“I believe in the ‘decent minimum’ principle of equity, but I do not believe
that justice demands that everybody have exactly the same system and style of care.”); see also
PRESIDENT’S COMMISSION FOR THE STUDY OF ETHICAL PROBLEMS IN MEDICINE AND BIOMEDICAL
AND BEHAVIORAL RESEARCH, SECURING ACCESS TO HEALTH CARE: THE ETHICAL IMPLICATIONS
OF DIFFERENCES IN THE AVAILABILITY OF HEALTH SERVICES (1983) (declaring ethical
appropriateness of some inequality as long as a decent minimum level of care is socially guaranteed).
4. Because it would dethrone established interests, empower consumers, and subvert conven-
tional wisdom, serious market reform would be radical indeed.  Cf. James C. Robinson, Taking Con-
sumers’ Rights Seriously, HEALTH AFF., Fall 1996, at 277, 277 (reviewing HAVIGHURST, HEALTH
CARE CHOICES, supra note 3) (describing it as “rag[ing] . . . through the Augean stables of health
policy discourse, filled as they are with intellectual leavings of medical, legal, and bureaucratic elites
that for decades have denied consumers their rights under the pretense of promoting those rights and
enfeebled the citizenry under the pretense of protecting it”).
5. See Agrawal & Veit, supra note 2, at 20-25; Robert A. Berenson, Beyond Competition,
HEALTH AFF., Mar.–Apr. 1997, at 171, 171 (noting that “[t]he logic of managed competition suggests
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highly successful early models of prepaid health care, particularly the Kaiser
Foundation Health Plan, Inc.6  Unfortunately, modern health plans do not
replicate those early, highly integrated models.  Even the Kaiser system, while it
continued to perform very well relative to other arrangements in the managed
care era, encountered difficulty in creating fully integrated organizations in new
areas.  Likewise, few new health plans, whether start-ups, evolving group
medical practices, or innovating health insurers, succeeded in integrating
financing, physicians, and capital resources to the same extent that Kaiser did at
an early date.  Indeed, Kaiser remains virtually unique, in its few core markets,
as a stable and effective partnership combining a nonprofit health plan, a
nonprofit hospital system, and a fully integrated multi-specialty medical group
dedicated solely to caring for a single plan’s enrollees.7
Market theorists, who hoped to see health care viewed and treated more
like a consumer good, have had even more reason to be discouraged by the
outcome of the health care revolution.  Among other things, the market reform
strategy contemplated that consumers, if offered opportunities to choose
effective health plan agents for purchasing services and organizing care, would,
for the first time, be given choices with different price tags reflecting different
trade-offs between quality and cost.8  Like the organizational reformers, market
reformers envisioned the domestication of providers in integrated
that within each health care market, networks with different and distinct organizational characteristics
and internal cultures will form and compete” but that “[h]ealth care markets have not evolved that
way”).
6. See generally JAMES C. ROBINSON, THE CORPORATE PRACTICE OF MEDICINE: COMPETITION
AND INNOVATION IN HEALTH CARE 74-75 (1999); Jerry Phelan et al., Group Practice Prepayment: An
Approach to Delivering Organized Health Services, 35 LAW & CONTEMP. PROBS. 796 (Autumn 1970)
(describing Kaiser’s foundational principles).
7. See generally Jeff C. Goldsmith, Integrating Care: A Talk with Kaiser-Permanente’s David Law-
rence, HEALTH AFF., Jan.–Feb. 2002 at 39.  For a discussion of the possibility that Kaiser’s performance
is superior to that of other HMOs, see Joseph Gottfried & Frank A. Sloan, The Quality of Managed
Care: Evidence from the Medical Literature, 65 LAW & CONTEMP. PROBS. 103, 113 (Autumn 2002).
The managed care revolution saw a number of nonprofit HMOs develop early, only to be converted to
for-profit status by managements seeking to capitalize on investors’ interest in HMOs.  Ironically,
today’s consumers, who have come to distrust HMOs, see infra Part V, might have greater confidence
in plans of the nonprofit variety.  Cf. Henry B. Hansmann, Reforming Nonprofit Corporation Law, 129
U. PA. L. REV. 497, 501-11 (1981) (explaining value of nonprofit firms’ “nondistribution constraint” to
“patrons” unable to evaluate the specific services such firms deliver).  Yet tax authorities have made it
difficult for nonprofit HMOs to gain tax-exempt status, cutting off sources of needed capital.  See, e.g.,
Geisinger Health Plan v. Comm’r, 985 F.2d 1210 (3d Cir. 1993); IHC Health Plans, Inc. v. Comm’r, 82
T.C.M. (CCH) 593 (2001).
8. On the trade-offs in medical care, see Havighurst & Blumstein, Coping, supra note 3, at 12-20
(presenting graphic conceptualization of the “quality/cost no man’s land,” in which no one wants to
engage the enemy but in which the battle for efficiency must be fought).  Welfare economics teaches us,
of course, that trade-offs matter generally in the economy, that quality is not an absolute goal, and that
cost-benefit analysis is justified.  Cf. United States v. Carroll Towing Co., 159 F.2d 169, 173 (2d Cir.
1947) (setting forth the famous “Learned Hand” test for negligence, which compares the cost of the
potential harm, discounted by its probability, with the cost of preventing its occurrence).  Today’s
health plans, however, have generally not gone so far as to embrace cost-benefit analysis, focusing their
cost-containment efforts instead only on “cost effectiveness” and the elimination of services and incre-
mental costs that seem to yield no marginal benefit at all.  See generally HAVIGHURST, HEALTH CARE
CHOICES, supra note 3, at 92-153.
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organizations.  However, they also hoped that competition would cause health
plans to cater to differing consumer preferences, seeking in particular to give
good value for whatever various subsets of consumers might choose to spend on
health coverage.  Obviously, the market reformers’ vision has also not been
realized—even though the health care industry has been functioning under an
ostensibly competitive regime for many years and has featured numerous firms
offering competing versions of managed health care.
This article begins by noting in Part II the gains made during the
revolutionary years of health care reform.  The next three Parts then consider
seriatim why the health care system failed to reach three specific objectives
envisioned by reformers: (1) organizational integration of the delivery of health
care with its financing; (2) market responsiveness to a full range of consumer
preferences; and (3) the creation of middlemen whom consumers could trust as
their agents for administering coverage and protecting premium pools against
moral hazard.9  In Part VI of the article, I observe some complexities in both the
private market for health coverage and the political market for regulatory and
other policies that help to explain the main shortfalls of the health care
revolution and the strength of the counter-revolution against managed care.10
My special concern is the fate of early hopes for a market regime in which
decisions would be driven principally by the preferences of cost-conscious,
appropriately subsidized consumers.11  After bluntly characterizing American
health care today as a regime designed principally by and for its elite consumers
and providers at the expense of lower- and middle-income premium payers, I
conclude with a few speculations about what may happen next.
II
GROUND GAINED
Despite the disappointments of would-be reformers, the health care
revolution has generated some very significant gains on behalf of consumers
that are unlikely to be lost entirely in the current counter-revolution.  Most
importantly for the empowerment of consumers, major players in the health
care industry, including the organized medical profession, have been clearly
9. “Moral hazard” is the term economists use to capture the distortion in spending decisions that
occurs when decision-makers are spending or risking funds other than their own.  For the argument
that moral hazard associated with health coverage, although it generates additional spending, would not
be inefficient in welfare terms if health plans were free to counteract its influence, see infra text accom-
panying note 84.
10. On the public backlash against managed care, see generally Clark C. Havighurst, The Backlash
Against Managed Health Care: Hard Politics Make Bad Policy, 34 IND. L. REV. 395 (2001) [hereinafter
Havighurst, Backlash]; David A. Hyman, Regulating Managed Care: What’s Wrong with a Patient Bill of
Rights?, 73 S. CAL. L. REV. 221 (2000); Symposium, The Managed Care Backlash, 24 J. HEALTH POL.
POL’Y & L. 873 (1999).  See also Havighurst, supra note 1 (discussing the validity of characterizing
health care’s recent history as one of revolution and counter-revolution).
11. For an expression of early hopes for a truly democratic health care revolution, see Clark C.
Havighurst, The Changing Locus of Decision Making in the Health Care Sector, 11 J. HEALTH POL.
POL’Y & L. 697 (1986).
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subject to the antitrust laws since 1975 and have modified their behavior
accordingly, no longer acting collectively to restrict the ways in which
consumers can purchase health services.12  Together with legislation clarifying
that health insurers may engage in selective contracting with providers,13 early
antitrust enforcement enabled health plans for the first time to act as purchasing
agents for their subscribers, awarding their principals’ business to providers who
agreed to charge acceptable prices and to cooperate with the plan in other
ways.14  Managed care plans have achieved most of their cost savings by
extracting competitive price discounts from subcontracting providers rather
than by efficiently managing the delivery of care (as HMO supporters
envisioned).15  Unfortunately, even though the antitrust regime remains in place
de jure as a permanent accomplishment of the health care revolution,16 it has not
12. The watershed event was Goldfarb v. Va. State Bar, 421 U.S. 773 (1975) (clarifying that the
Sherman Act applies to the so-called “learned professions,” including medicine).  See generally Clark C.
Havighurst, Health Care as a (Big) Business: The Antitrust Response, 26 J. HEALTH POL. POL’Y & L.
939, 942 (2001) (“Few things could have had as revolutionary an effect on the health care sector as the
abrupt overturning of the deep-seated policy of trusting medical interests to make and enforce industry
rules and set standards for the health care field.”).  Goldfarb had a profound effect not only on the
health care marketplace but also on the substance and direction of national health policy.  “After it,
policy-makers could and did begin to look to market forces [instead of public regulation] to allocate
resources and guide the industry’s development.”  Id. at 942-43.
13.  So-called preferred-provider arrangements got a surprising lift in 1982, when the California
legislature not only provided for selective contracting with hospitals under Medicaid but also enacted
unheralded amendments expressly allowing private insurers to engage in similar selectivity toward pro-
viders of all kinds.  CAL. WELF. INST. CODE § 14083 (West 2001).  Other states quickly moved to clar-
ify the legality of insurers’ efforts to steer their insureds to selected providers.
14. Traditional health insurance permitted free choice of provider, largely because providers
insisted that payers should not “practice medicine” by making choices for consumers.  See Charles D.
Weller, “Free Choice” as a Restraint of Trade in American Health Care Delivery and Insurance, 69
IOWA L. REV. 1351, 1351 (1984) (“[T]he AMA’s free choice ethics, consistent with guild precepts, pre-
vents providers from being split into groups competing over price.  Market free choice, consistent with
market principles, permits price as well as nonprice competition among providers.”).  The leading cases
clarifying that collaborating professional competitors cannot prevent health plans from serving as pur-
chasing agents for consumers include FTC v. Ind. Fed’n of Dentists, 476 U.S. 447 (1986) (upholding
finding that dentists unlawfully restrained trade by agreeing not to provide x-rays that would allow
insurers to review proposed treatments); Ariz. v. Maricopa County Med. Soc’y, 457 U.S. 332 (1982)
(medical society’s maximum fee controls held unlawful because “insurers are capable . . . of obtaining
binding agreements with providers [with respect to fees]”); Am. Med. Ass’n v. FTC, 638 F.2d 443 (2d
Cir. 1980) (invalidating professional ethical codes that bar physician contracting with insurers).
15. Stephen Heffler et al., Health Spending Growth Up in 1999; Faster Growth Expected in the
Future, HEALTH AFF., Mar./Apr. 2001, at 193, 194 (“Declines in price growth between 1988-93 and
1993-1998 account for more than two-thirds of the slowdown in spending growth.”); David M. Cutler et
al., How Does Managed Care Do It?, 31 RAND J. ECON. 526 (2000) (empirical study of experience
with treating heart disease in Massachusetts, finding as follows: “HMOs reimburse only a little over half
what indemnity insurance pays for the same procedure.  But the rates of procedure use and adverse
outcomes across plans are relatively similar.”).  But see MARTIN GAYNOR ET AL., INCENTIVES IN
HMOS (Nat’l Bureau of Econ. Research, Working Paper No. 8522, 2001) (reporting that financial
incentives in one HMO induced saving of five percent in utilization costs).  For the view that antitrust
law itself needs to be further revolutionized by placing less emphasis on price competition and giving
weight to the non-price (quality) dimensions of health care, see William M. Sage & Peter J. Hammer, A
Copernican View of Health Care Antitrust, 65 LAW & CONTEMP. PROBS. 241 (Autumn 2002).
16. It seems unlikely that health care providers will ever recapture the raw economic power they
possessed when they were largely free to act as a cartel, policing the industry at key points.  Even the
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prevented consolidation of hospitals and physician groups from restoring some
of the providers’ market power de facto.17  In addition, the counter-revolution
against managed care has yielded new legal limitations on the freedom of health
plans to select providers and to “deselect” them at will, subject only to
contractual commitments.18  Plans are thus less able to negotiate low prices with
individual physicians in return for an assured supply of patients and to demand
cooperation with the plan and adherence to its policies.
In addition to fostering selective contracting, enforcement of the antitrust
laws against professionals allowed health plans to adopt the practice of
“predetermining” coverage.  This method of rationing health care financing,
which physicians resisted collectively with great success in the pre-antitrust era,19
is advantageous for several reasons.  Not only does it allow plans to effectuate
contractual limitations on coverage before costs are incurred, but it often
enables plan medical directors to persuade the treating physician to prescribe a
Supreme Court’s recent decision in Cal. Dental Ass’n v. FTC, 526 U.S. 756 (1999), which seemed to
reopen doors previously closed to anticompetitive professional self-regulation, is not likely to change
anything very much, although courts and plaintiffs may feel that more proof is now required to estab-
lish the illegality of certain restraints of trade.  Major legislative change is also unlikely.  Thus, although
Congress recently entertained a proposal to create an antitrust exemption allowing physicians to
engage in collective bargaining with health plans, the attention given that bill, mostly in the House of
Representatives, probably reflected its value in procuring campaign contributions more than its actual
appeal as a policy measure.  See Carl F. Ameringer, Federal Antitrust Policy and Physician Discontent:
Defining Moments in the Struggle for Congressional Relief, 27 J. HEALTH POL. POL’Y & L. (forthcom-
ing Aug. 2002) (examining politics of antitrust exemptions for physicians).  Several states, relying on
federal antitrust law’s “state action” exemption, have authorized certain kinds of concerted action by
providers under state supervision.  E.g., N.C. Gen. Stat. §§ 131E-192.1–.13 (1996) (authorizing coopera-
tive agreements by hospitals, including mergers); N.J. Stat. Ann. §§ 52:17B–196-209 (West 2002)
(authorizing limited collective bargaining by physicians with health plans).  See generally James F.
Blumstein, Health Care Reform and Competing Visions of Medical Care: Antitrust and State Provider
Cooperation Legislation, 79 CORNELL L. REV. 1459 (1994).  These laws, however, are reported to have
had only limited practical effect.  James F. Blumstein, Assessing Hospital Cooperation Laws, 8 LOY.
CONSUMER L. REV. 98, 105 (1995-96) (reporting few hospital mergers under such laws); Amy Snow
Landa, N.J. Doctors Get Collective Bargaining Rights, AM. MED. NEWS, Jan. 28, 2002, at 5 (reporting
that, because New Jersey and similar states do not give physicians a right to strike, health plans have
little incentive to bargain with them).
17. See Thomas L. Greaney, Whither Antitrust? The Uncertain Future of Competition Law in
Health Care, HEALTH AFF., Mar./Apr. 2002, at 185 (observing some failures in antitrust enforcement in
the health sector); Barbara Martinez, With New Muscle, Hospitals Squeeze Insurers on Rates, WALL ST.
J., Apr. 12, 2002, at A1; Joseph Weber, The New Power Play in Health Care, BUSINESS WEEK, Jan. 28,
2002, at 90 (noting how managed care plans are losing the upper hand in negotiations over price and
other issues, as providers merge and otherwise consolidate for bargaining purposes).
18. See, e.g., 24-A Maine Rev. Stat. § 4303 (2001); N.Y. Pub. Health L. § 4406-d (2001); Potvin v.
Metropolitan Life Ins. Co., 997 P.2d 1153 (Cal. 2000); Harper v. Healthsource N.H., Inc., 674 A.2d 962
(N.H. 1996); Jill A. Marsteller et al., The Resurgence of Selective Contracting Restrictions, 22 J. HEALTH
POL. POL’Y & L. 1133 (1997).  On state “any-willing-provider” laws, see Ky. Ass’n of Health Plans, Inc.
v. Nichols, 227 F.3d 352 (6th Cir) (holding Kentucky law protecting providers’ right to participate in
health plans not preempted by federal law) cert. granted, 122 S.Ct 2655 (2002); CIGNA Healthplan, Inc.
v. Louisiana ex rel. Ieyoub, 82 F.3d 642 (5th Cir. 1996) (holding Louisiana law preempted).
19. The necessary physician cooperation could not be obtained as long as physicians could collec-
tively refuse to cooperate without fear of antitrust action.  See United States v. Or. State Med. Soc’y,
343 U.S. 326, 336 (1952) (implying, in dicta, great antitrust tolerance for physician boycotts of payers
pursuing practices objectionable to physicians).  Cf. FTC v. Ind. Fed’n of Dentists, 476 U.S. 447 (1986).
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less costly course; indeed, many physicians modify their demands simply
because they know a payer is watching.20  Predetermination of benefits is both
cumbersome and controversial, however, especially if the treating physician is
not committed to the plan and its agenda.21  Consumers have therefore enjoyed
only limited savings from health plans’ new ability to scrutinize physicians’
clinical decisions.  Predetermination of benefits also has been a particular target
of one-sided media exposés and of legislation further hampering efforts by
health plans to counteract moral hazard by strictly administering their
contracts.22
In the early days of the health care revolution, another breakthrough—
second in importance only to the antitrust initiative—threatened to embolden
health plans in monitoring physicians.  This development was the appearance of
research showing that physicians’ practice patterns varied substantially, and
inexplicably, from place to place and that many customary clinical practices
lacked convincing evidence of their efficacy in improving health status.23  A
clear implication of these studies was that all was not well inside the black box
of clinical medicine and that, contrary to what the medical profession had led
the public to believe, much conventional practice lacked a scientific foundation.
The revolutionary implications of these findings were clear, since they positively
invited health plans to take managerial initiatives on behalf of their subscribers.
Professional organizations, however, seeing the explosive possibilities, quickly
took preemptive action to reestablish professional authority by promulgating
authoritative “guidelines” for clinical practice.24  To be sure, the consuming
public has benefitted from the medical profession’s efforts to strengthen the
scientific base of professional practice and from physicians’ increasing
recognition of an obligation to practice “evidence-based” medicine.  But the
20. See generally Rosenberg et al., Effect of Utilization Review in a Fee-for-Service Health Insur-
ance Plan, 333 NEW ENG. J. MED. 1326 (1995).
21. Physicians are sometimes said to have a duty to serve as “advocates” for their patients.  If the
physician has not accepted the legitimacy of a health plan’s basic limitations on coverage, however,
advocacy can be disruptive of plan efforts to control costs in the interest of its subscribers.  See generally
William M. Sage, Physicians as Advocates, 35 HOUS. L. REV. 1529 (1999).  On the other hand, a plan
could and should expect its physicians to keep its contract administrators aware of all relevant facts
(and their arguable clinical significance) in each case so that each patient gets what he has coming
under his contract.
22. On restrictive state legislation, see generally Frank A. Sloan & Mark A. Hall, Market Failures
and the Evolution of State Regulation of Managed Care, 65 LAW & CONTEMP. PROBS. 169 (Autumn
2002). See also infra Part V.D.
23. E.g., JOHN M. EISENBERG, DOCTORS’ DECISIONS AND THE COST OF MEDICAL CARE: THE
REASONS FOR DOCTORS’ PRACTICE PATTERNS AND WAYS TO CHANGE THEM (1986); JOHN E.
WENNBERG ET AL., THE DARTMOUTH ATLAS OF HEALTH CARE IN THE UNITED STATES (1996);
Mark R. Chassin et al., Variations in the Use of Medical and Surgical Services by the Medicare Popula-
tion, 314 NEW ENG. J. MED. 285 (1986); David M. Eddy, Clinical Policies and the Quality of Clinical
Practice, 307 NEW ENG. J. MED. 343, 343 (1982) (finding “reason to believe that there are flaws in the
process by which the profession generates clinical policies”); John E. Wennberg, Dealing with Medical
Practice Variations: A Proposal for Action, HEALTH AFF., Summer 1984, at 6.
24. See generally INSTITUTE OF MEDICINE, CLINICAL PRACTICE GUIDELINES: DIRECTIONS FOR
A NEW PROGRAM (Marilyn J. Field & Kathleen N. Lohr eds., 1990); Clark C. Havighurst, Practice
Guidelines for Medical Care: The Policy Rationale, 34 ST. LOUIS U. L.J. 777 (1990).
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profession’s reassertion of authority over clinical practice perpetuated the old
paradigm of medical care, which contemplates that choices will be driven solely
by medical expertise, not by third-party middlemen or consumers’ cost
concerns.25  Thus, health plans, while free to enforce professional standards in
predetermining coverage, are largely precluded from taking an independent
hand in rationalizing health care spending to meet the needs of particular
segments of the population.  Consumers therefore remain locked in a system
that gives them few real choices—few opportunities, that is, for significant
economizing.
With only limited ability to ration financing explicitly through coverage
decisions, health plans also seek to control costs by inducing their provider-
subcontractors to assume substantial financial risks for the care they undertake
to provide.  While this strategy lacks the openness and reviewability of explicit
coverage decisions, the absence of transparency has proved a strength in
practice, because providers’ sub-rosa rationing of care is less likely to attract
media criticism and political or legal attacks.26  Moreover, reformers principally
interested in fostering organizational integration of financing and delivery
generally find capitation and other incentive arrangements with subcontractors
to be a positive development, since such methods of payment encourage
collective responsibility for the cost as well as the quality of care.27  A market
25. See Havighurst, supra note 24, at 785 (“[M]ost observers view the problems revealed by the
new research strictly in accordance with the pure professional paradigm—as simply a rectifiable failure
of scientific research, professional standard setting, and continuing medical education.  Under this view,
what is needed is simply more diligence by professional groups in determining what services work best
and increased efforts to inform physicians of the conclusions reached.  The assumption continues to be
that, despite the demonstrated deficiencies of past performance, physicians left to their own devices
with improved professional guidance will provide optimal care.”).  For a recent reminder that physi-
cians cannot be trusted not to overtreat patients for financial reward, see Jerome Groopman, A Knife
in the Back, THE NEW YORKER, Apr. 8, 2002, at 66 (describing extensive use of unproved back sur-
gery).
26. Challenges to provider rationing usually take the form of an ordinary malpractice claim against
the provider for omitting precautions required by the standard of care.  Several cases, however, have
aimed, mostly unsuccessfully, at HMOs themselves for adopting incentive systems that arguably co-opt
physicians, inviting them to engage in undue economizing.  E.g., Pegram v. Herdrich, 530 U.S. 211
(2000) (rejecting challenge to physician incentives in HMOs); Maio v. Aetna, Inc., 221 F.3d 472, 499 (3d
Cir. 2000) (“[W]e must decline appellants’ invitation to pass judgment on the social utility of Aetna’s
particular HMO structure.”); Ehlmann v. Kaiser Found. Health Plan of Tex., 198 F.3d 552 (5th Cir.
2000), cert. dismissed, 530 U.S. 1291 (rejecting class action attacking physician incentives); Shea v.
Esensten, 107 F.3d 625 (8th Cir. 1997) (recognizing duty to disclose incentives); Weiss v. Cigna
Healthcare, Inc., 972 F. Supp. 748, 753 (S.D.N.Y. 1997) (“[P]laintiff’s concern about the soundness of
managed care policy is best suited for resolution by branches of government other than the judiciary.”).
27. E.g., Meredith B. Rosenthal et al., Managed Care and Market Power: Physician Organizations
in Four Markets, HEALTH AFF., Sept./Oct. 2001, at 187, 192 (“Many believe that the future of managed
care lies in the devolution of clinical management and financial decision making to [physician organiza-
tions].”).  In fact, many provider organizations accepting what is to a large extent an insurance risk have
run into severe financial difficulties because they have underestimated the difficulty of managing such
risks, particularly the difficulty of overcoming participating providers’ resistance to cost-control meas-
ures.  See id. (“[M]any of the physician organizations in the markets we visited had difficulty adapting
to risk contracting because they lacked the proper systems and skills needed to manage risk effec-
tively.”).
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reformer might remain critical, however, because shifting financial risks to a
variety of subcontracting providers largely deprives the health plan of the
ability to implement a distinctive style of care, thereby differentiating itself from
its competitors and giving consumers a meaningful alternative in the
marketplace.  In any event, risk contracting has been a widely used cost-
containment tool in modern health plans.28
In general, it appears that the health care revolution did succeed in
empowering consumers in at least one substantial way—by giving them agents
who can both effectively negotiate with providers on their behalf over fees and
procure care on something other than a fee-for-service basis.29  As a
consequence of health plans’ ability to force providers to compete on the basis
of price, consumers pay less for their services than they would have paid under
pre-revolutionary arrangements.  In addition, the evidence suggests that these
savings have been achieved with no net sacrifice in the quality of care.30
Consumers’ gains stop there, however, for health plans never succeeded in
parlaying their new freedom of action under the antitrust laws into substantial
power over anything but price.  They therefore remain largely unable to give
effect to differing consumer preferences concerning the content, intensity, and
quality of medical care.31  Moreover, there is scant interest among policy-makers
in having them assume such responsibilities.  Indeed, managed care plans are
constantly scrutinized for signs that they offer services that are inferior in any
way to services under traditional financing systems—the clear implication being
that cost savings are appropriate only if they come at no sacrifice of quality.32
And, as will be seen, the professional paradigm of medical care, with its premise
that any arguable benefit from health care is worth paying for, still dominates
legal doctrine, political discourse, and media coverage.  Thus, while the health
care revolution has yielded some real cost savings for consumers, the
revolutionary idea that consumers should be empowered to make choices
28. Today, however, provider entities are growing less eager to accept financial risk.  James C.
Robinson, The End of Managed Care, 285 JAMA 2622, 2624 (2001) (“Physician organizations are
retreating from global capitation to partial capitation, case rates, or fee-for-service; are renouncing or
losing authority for utilization review and claims processing; and are quietly abandoning the rhetoric of
disintermediating the health insurance plans.”).
29. A major problem in health care is the difficulty of defining discrete, uniform units of output for
purposes of contracting and payment.  See infra text accompanying notes 59-61.  One major accom-
plishment of the purchasing revolution was the introduction of new payment methods besides fee-for-
service, such as payment by capitation or by “diagnosis-related group.”
30. See generally Gottfried & Sloan, supra note 7.
31. This observation goes far toward explaining the finding of Cutler et al., supra note 15, that
HMOs have not greatly modified clinical practice.
32. See Gottfried & Sloan, supra note 7, at 137 (reviewing numerous studies comparing quality
without appreciable allowance for cost differences and concluding that, even without regard to
cost savings, managed care is “as fit for popular consumption as traditional, less affordable
indemnity insurance”).  Poorer quality in some areas is apparently acceptable if it is offset by quality
improvements in other areas, so that net quality does not suffer.  Neither critics of managed care nor
analysts responding to their criticisms are inclined to fault managed care for failing to deliver on its
promise to improve overall quality.
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involving consequential trade-offs in procuring health care has yet to gain
traction either in health policy or in the marketplace.
Imperfect as they were, many of the specific tools that health plans
developed for controlling costs in the revolutionary era are being blunted
further by regulation or made subject to new liability risks poorly calibrated to
real wrongdoing.33  Even though the political and legal backlash against
managed care may not wholly disable health plans de jure as middlemen making
choices on behalf of consumers, the managed care industry may interpret it as a
definitive repudiation of their efforts to manage care independently as a service
to their subscribers.34  Never very adventuresome or independent under the best
of circumstances, managed care firms may now exhibit still more of the herd-
mentality characteristic of most heavily regulated industries.  In industries
where the parameters of competition are narrowly set by heavy governmental
regulation, individual firms have too little independence or energy left to cater
to the needs of consumers.35  In this climate, consumers are in danger of losing
even more of the ground they gained during the health care revolution.
More important than the net ground gained by consumers, however, is the
remaining distance left to the revolution’s ultimate democratic goal—full
empowerment of consumers.  This article’s next three sections examine some
specific reasons why, despite early revolutionary changes in some rules of the
health care game, today’s health plans, the players upon whom consumers must
rely to move the ball, have made few inroads into provider territory.  It will be
seen that health plans, though hefty enough for some defensive purposes, are
poorly organized and slow afoot, have too few options in their play books, and
are hampered by rules held over from pre-revolutionary days.  They also have
earned too little fan support to enjoy any kind of home-field advantage.
Because health plans fall short in all of these respects, the great majority of
today’s consumers of health care have little to cheer about.
III
HEALTH PLANS’ FAILURE TO INTEGRATE PROVIDERS AND FINANCING
Virtually all of today’s health plans are essentially general contractors,
bearing some financial risk but well-distanced from the actual delivery of
services.  Thus, they remain merely payers, not providers of care capable of
imposing effective control over providers’ practices with a view to improving
quality, realizing available efficiencies, and giving effect to their subscribers’
preferences.  Only the Kaiser-Permanente system seems to be integrated to
33. Sloan & Hall, supra note 22; see also infra Part VI.D.
34. See, e.g., Robinson, supra note 28, at 2627 (“[N]ever again will they succumb to the bait-and-
switch gambit used by government and employers, who exhorted them to control health care costs and
then vilified them for using the marketplace mechanisms that were at their disposal.”).
35. Even if an industry member were tempted to strike out in a new direction, the new political and
legal environment has made creative innovation even costlier and riskier for individual firms.  No single
firm  is therefore likely to essay any controversial innovation that competitors could emulate once the
first mover had cleared the way.
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such a degree and in such a way that it could, if it wanted, offer the public a
uniform set of services reflecting well-founded, well-considered, and consistent
policies for spending a fixed pool of premiums on health services for an enrolled
population.  Indeed, as promising as the Kaiser system once was as a model for
reorganizing the health care industry, its continuing exceptionalism confirms
the general rule that most health plans, even those nominally organized as
HMOs, have little more ability to influence the actual hands-on delivery of care
than indemnity insurers had in the earlier fee-for-service era.36  Although many
of their subcontractors are themselves integrated in substantial ways, health
plans remain generally unintegrated, presiding over an archipelago of
subcontractors all doing very much their own thing within the range of what is
professionally acceptable.
There are, to be sure, many obstacles to integrating both health care
financing and providers in effective competitive units.  For example, any health
plan that is large enough to realize economies of scale in performing its core
insurance functions, including marketing, risk spreading, and contract
negotiation, would be likely to encounter substantial diseconomies of scale in
attempting to manage care itself.37  The original Kaiser plan overcame this
problem by employing a totally integrated physician group wholly dedicated to
caring for Kaiser’s enrolled population.  And that business model probably
succeeded only because Kaiser was able to begin small, in isolated
environments, and to grow both its enrollment and its physician groups
gradually over a long period without appreciable competition from health plans
pursuing comparable strategies.  Health plans of more recent vintage have been
unable to get started in the same way, by home-growing comparable physician
groups from scratch.38  Although some expected at one time that health plans
36. In 1998, Zelman and Berenson, two reformers discouraged by what they saw as a trend away
from the hoped-for integration of financing and delivery, observed as follows:
[T]he most recent trends suggest that . . . managed care plans may wind up watering down
their products to such a degree that the potential for real coordination and for cost and quality
control may be lost.  Today much of managed care—with expanding networks of physicians
and groups, easier access to specialists, and in some situations, less intrusive utilization
review—is beginning to look and act ominously like the old fee-for-service system . . . .
WALTER A. ZELMAN & ROBERT A. BERENSON, THE MANAGED CARE BLUES AND HOW TO CURE
THEM 12 (1998).
37. See Thomas Palay, Organizing an HMO by Contract: Some Transaction Cost Considerations, 65
NEB. L. REV. 728, 746 (1986) (noting that a “group practice can take advantage of close physician
proximity to foster a strong social structure and communication network [with] norms . . . established
by example rather than by fiat,” whereas looser, larger organizations “must rely more heavily upon
formal processes, meetings, and rules”); James C. Robinson, The Future of Managed Care Organiza-
tions, HEALTH AFF., Mar./Apr. 1999, at 7, 18-19 (explaining “the economics of vertical disintegration”
and observing, “[t]he administrative, information, and clinical competencies required for an organiza-
tion that actually delivers health care are quite distinct from those of an organization that develops,
markets, and monitors contractual networks”). Query whether information technology will eventually
enable large health plans to coordinate care and monitor unintegrated physician networks and thus to
deliver a uniform, customized products.
38. Staff model HMOs, in which physicians are essentially employees and fully integrated into the
plan, either did not materialize or failed to prosper, partly because employers demanded greater free-
dom of choice for their employees.  See generally ROBINSON, supra note 6, at 71-83.
HAVIGHURST_FMT.DOC 10/23/02  1:50 PM
66 LAW AND CONTEMPORARY PROBLEMS [Vol. 65: No. 4
could achieve efficiency through loose affiliations and contractual relations with
providers,39 relationships created by such “virtual” integration proved unstable
and prone to opportunism; they were also too attenuated to allow the plan to
coordinate care and bring physician behavior into line with plan policy.40
In practice, it has proved nearly impossible for health plans other than
Kaiser to engage physicians and other providers in long-term, committed
relationships.  In relating to health plans, physicians have strongly adhered to
the traditional paradigm of medical care, under which they practice their
profession in their own way, subject to professional norms alone, and payers are
expected to support them without question in that endeavor.  Moreover, most
physicians and hospitals contract with managed care organizations only to fill
their appointment books or beds, and they ensure their independence by
contracting with as many plans as possible.  The Kaiser system itself had
difficulty recruiting physicians in the early years, succeeding only because it
offered a unique practice option that a subset of physicians found attractive for
personal or ideological reasons (or perhaps because they were foreign medical
graduates lacking attributes necessary for easy success in the fee-for-service
world).  Early HMO proponents expected that certain preexisting medical
groups, including multi-specialty group practices, hospital medical staffs, and
faculty practice plans in academic medical centers, would be capable of
operating as HMOs or the equivalent.  Such groups, however, have proved
generally unwilling to drop their lucrative fee-for-service business and commit
themselves exclusively to serving as the sole provider for enrollees of a single
plan.
A key reason why the hoped-for integration of physicians into competing
health plans never occurred is that the marketplace still provides only weak
incentives for improving the quality and efficiency of care.  Because consumers
are not good judges of the quality of the medical care they receive, health plans
can advertise their interest in quality without actually doing very much to
maintain or improve it.41  Moreover, the legal system, instead of filling this gap
in consumer information by imposing legal liability on plans when quality fails,
has remained true to the traditional paradigm, under which quality is a matter
entirely between the provider and the patient.42  Interestingly, the Kaiser system
39. See, e.g., Jeff C. Goldsmith, The Illusive Logic of Integration, HEALTHCARE F.J., Sept.–Oct.
1994, at 26 (questioning the presumed benefits of much of the organizational integration sweeping the
health care industry and suggesting virtual integration might serve as well); Clark C. Havighurst &
Glenn M. Hackbarth, Private Cost Containment, 300 NEW ENG. J. MED. 1298, 1299 (1979) (identifying
“new opportunities for experimentation and change that lie on the broad—and largely unexplored—
spectrum from traditional financing mechanisms to . . . [highly integrated] HMOs”).
40. See generally ROBINSON, supra note 6, at 63-89.
41. Class action lawsuits have been filed charging HMOs with misrepresenting themselves to con-
sumers on a number of points, including their commitment to quality.  See In re Managed Care Litiga-
tion, 185 F. Supp. 2d 1310 (S.D. Fla. 2002); Clark C. Havighurst, Consumers Versus Managed Care: The
New Class Actions, HEALTH AFF., July/Aug. 2001, at 8, 15-16 (describing and evaluating class action
complaints charging HMOs with falsely advertising their commitment to quality).
42. The strength of the paradigm can be seen in Petrovitch v. Share Health Plan, Inc., 719 N.E.2d
756 (Ill. 1999), in which the court imposed vicarious liability for a physician’s tort on an HMO—but
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picked up on the revolutionary idea that there should be a single locus of
responsibility for both cost and quality at an early date, by voluntarily accepting
corporate liability for provider malpractice.43  Thus, Kaiser’s exceptionalism
again reveals how the post-revolutionary marketplace omits the focused
accountability necessary to realize the reformers’ vision of improved health
care.
It is hard to imagine a worse arrangement than allowing for-profit health
plans to assume corporate responsibility for the cost of care while avoiding any
legal responsibility for its quality.  Yet this is precisely the situation that prevails
today.44  Contrary to reformers’ visions, virtually all of today’s health plans, like
health insurers in the fee-for-service era, remain essentially financers of care the
content of which is decided upon for the most part by distant, nonexclusive
subcontractors and the physicians they select.  The health care revolution has
thus failed to deliver on its promise to create organizational structures in which
physicians cooperate with payers and with each other in managing both quality
and cost in the interest of self-selected subsets of the consuming public.
IV
HEALTH PLANS’ FAILURE TO OFFER CONSUMERS REAL CHOICES
Some critics of the old health care system hoped that integrating the
financing of health care with its delivery not only would bring order out of
chaos in clinical practice but would also allow consumers to treat health care
more like an ordinary consumer good, choosing between expensive, ostensibly
low-risk, high-quality care and cheaper styles of possibly lesser quality.45  Little
progress has been made, however, toward creating competing entities capable
of offering health care that is significantly differentiated along qualitative lines.
only because the plan attempted in modest, generally accepted ways to influence professional practice.
The court clearly viewed vicarious liability as a punishment for plan interference with physicians, not as
an inducement for plans to take an active interest in the quality of care being delivered by its subcon-
tracting physicians.  See generally Clark C. Havighurst, Vicarious Liability: Relocating Responsibility for
the Quality of Medical Care, 26 AM. J. L. & MED. 7 (2000) (observing that courts have not routinely
imposed liability for provider malpractice on health plans but instead have generally left tort responsi-
bility solely on individual practitioners and hospitals).
43. William M. Sage, Enterprise Liability and the Emerging Managed Health Care System, 60 LAW
& CONTEMP. PROBS. 159, 175 (Spring 1997).
44. Havighurst, supra note 42, at 8 (observing and decrying this illogical arrangement and arguing
for the establishment of, as a default rule, “the principle that a health plan is vicariously, and exclu-
sively, liable for medical malpractice and other torts committed by health care providers whom it pro-
cures to treat its enrollees”); Havighurst, supra note 41, at 17 (opining that, in pending class actions, “a
material misrepresentation might be found when a plan advertises a general commitment to quality
while systematically denying any legal duty to maintain it”).  Given the prevailing insulation of health
plans from tort liability, it is surprising that quality is no worse than under fee-for-service financing;
indeed, better management should improve quality rather than merely maintain it.
45. See sources cited supra note 3.  For the argument that offering such choices is the principal
raison d’être of private financing of health care and that, without choice, the case for maintaining a pri-
vate system with high administrative costs is weak, see Clark C. Havighurst, Why Preserve Private
Health Care Financing?, in AMERICAN HEALTH POLICY: CRITICAL ISSUES FOR REFORM 87 (Robert
B. Helms ed., 1993).
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To be sure, some subcontractor-providers are organized and paid in ways that
permit and encourage substantial economizing.  But their undertaking to the
health plan and its enrollees is only to provide care in accordance with general
community standards, and their distance from the health-plan general
contractor does not allow the latter either to manage care directly in pursuit of
objectives of its own or to transmit its subscribers’ preferences effectively to the
actual providers of care.46  Only the Kaiser system is organized in a way that
might allow it to manage providers in pursuit of a plan-defined mission.
Without competition from plans with similar capabilities, however, Kaiser has
never found it necessary to offer contracts expressly differentiating its promises
from those of other health plans.  Organizational barriers separating health
plans from physicians are thus one apparent reason why all health plans offer
consumers essentially the same core coverage (all “medically necessary”
services) and the same nominal quality of care (whatever professional standards
require).47
There may be other, more fundamental reasons, however, why health plans
have not catered to the desires of individuals willing to accept some risk in
return for significant cost savings.  One might doubt, for example, that there is
any significant demand for low-cost health coverage involving explicit
assumption of risk; after all, consumers already have the option of going
without coverage altogether, saving the entire cost of purchasing protection by
taking their chances with the so-called “safety net.”  But, even though millions
of Americans have in fact chosen to free ride on society’s good nature in this
way (or to accept employment that does not offer health coverage as a fringe
benefit),48 there is another large group of individuals for whom health coverage
is an integral part of their compensation and who can save no more than a
fraction of its cost by refusing it.  Many, perhaps even a majority, of these
individuals are undoubtedly paying more than they would choose to spend if
46. Although plans sometimes impose modest requirements related to preventive services or other
measurable features of health care quality, they have rarely sought to ensure a generally high level of
performance or to make their providers’ practices more uniform by coordinating their efforts and
rationalizing their clinical methods.  See ROBINSON, supra note 6, at 115 (“[C]ontinuous quality
improvement . . . is coming only slowly to medical care.”).  Instead, any efforts they make to manage
clinical care are generally limited to some provider profiling, monitoring of the provision of certain
preventive services, occasional efforts to steer patients to “centers of excellence” for highly specialized
services, and imposing modest reporting and quality-related requirements on subcontractors.  Few
plans have been notably selective in their choices of subcontractors, screening for demonstrated compe-
tence and demanding organizational changes necessary for superior performance.  Instead, most plans
are pleased to cover the services of any generally cooperative provider willing to accept the plan’s
financial terms.
47. See infra notes 57, 63-69 and accompanying text.
48. See Jeff Bailey, Small Businesses Consider Cuts in Health-Care Benefits, WALL ST. J., Dec. 18,
2001, at B4 (citing a study by the Kaiser Family Foundation and Health Research and Educational
Trust: “[W]hile 99% of employers with 200 or more workers offer insurance, just 66% of the employees
are covered by those plans.  At companies with fewer than 200 workers, while 65% offer coverage, just
59% of workers are covered.”).  It is not clear how many employees rejecting coverage may possess it
through a spouse.
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reasonable economizing opportunities were offered.49  If everyone faced the full
cost difference between high- and low-cost coverage, there would certainly be
some takers for the bare-bones variety.50
Offering real health care choices is sometimes ruled out on the ground that
it would segment the risk pool and destabilize the insurance market—as
insurable consumers, with superior knowledge of their own future needs, seek
to outsmart sellers of coverage.  One concern is that poorer risks will gravitate
toward the most generous health plan, eventually causing a spiral in which that
plan’s increasingly high premiums drive all the still-insurable risks into lower-
cost plans.51  Employers and others managing the menu of choices could address
this potential problem, however, by severing the automatic link between the
premiums paid by individuals and the revenue each plan receives; thus,
premiums could be set realistically and then pooled, and distributed according
to the risk profile of each plan’s enrolled population.52  Under such an
arrangement, plans offering higher-quality coverage would remain price-
competitive for healthier consumers seeking maximum protection, and all plans
would be rewarded in some measure for appealing to higher risks.  Another
fear associated with offering real choices is that adverse selection would result if
consumers could upgrade their coverage whenever a major health problem
loomed; this problem could be ameliorated, however, “simply by allowing a
higher-priced plan that an enrollee seeks to join to restrict its coverage of any
preexisting condition to that provided under the enrollee’s previous plan.”53
Finally, it is possible that “niche” health plans designed for a lower-income or
risk-tolerant minority might be too small to achieve vital economies of scale in
many areas of plan administration.  In any event, the concept of offering
consumers real choices has never been put to a true market test—for a variety
of practical reasons explored below.
A. Hidden Costs, Employer Choices
A key reason for the low level of apparent consumer interest in low-cost
health care is the insulation of consumers from most of the cost of whatever
coverage they obtain.  Heavy tax subsidies, in the form of exclusions of
49. See infra text accompanying notes 102-113.
50. But see MARK A. HALL, REFORMING PRIVATE HEALTH INSURANCE 57 (1994); FAMILIES
USA, NO SALE: THE FAILURE OF BAREBONES INSURANCE (1993).  These sources report that very
few employers opted, when it was offered, for health insurance without certain state-mandated benefits
and with arbitrary dollar or other caps on coverage.  However, no plans have offered contracts explic-
itly and substantially curbing entitlements to marginally beneficial care, as proposed in HAVIGHURST,
HEALTH CARE CHOICES, supra note 3, at 157-302.
51. See generally DAVID M. CUTLER & RICHARD J. ZECKHAUSER, ADVERSE SELECTION IN
HEALTH INSURANCE (Nat’l Bureau of Econ. Research, Working Paper No. 6107, 1997).
52. Adjusting payments to reflect risks, however, is more easily proposed than done.  See, e.g.,
Joseph P. Newhouse, Risk Adjustment: Where Are We Now?, 35 INQUIRY 122 (1998); Symposium, Pri-
vate Employers and Risk Adjustment, 38 INQUIRY 242 (2001). But see CUTLER & ZECKHAUSER, supra
note 51 (reporting real-world experiences with adverse selection and suggesting possible responses by
employers in pricing coverage to individuals).
53. HAVIGHURST, HEALTH CARE CHOICES, supra note 3, at 53.
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employer-paid premiums from the bases on which income and payroll taxes are
levied, make employer-purchased health coverage a substantial bargain for
consumers; only through that route can all health bills be paid with untaxed
dollars, yielding effective discounts of more than forty percent for some
taxpayers (depending on applicable federal and state tax rates).54  In addition,
because most tax subsidies apply only when coverage is procured through an
employer, most individuals have employer-based coverage.  Most employers,
however, design their health benefits with the average worker, not individuals,
in mind.55  Moreover, only a generous plan sends workers the message most
employers want to convey about their concern for employee welfare.  For this
reason, and also because health benefits are useful in attracting and keeping
workers with the best chances of being hired by someone else, employee health
plans are likely to be costlier than even the average worker would demand
(even with tax subsidies enhancing his purchasing power).
While the interest of some employees in purchasing cheaper coverage is
often lost in the politics of employer/employee relations, some employers do
offer choices that may appeal to lower-income workers.  A limited number go
so far as to offer fixed contributions, allowing individuals to select a health plan
from a menu including low-cost options and requiring them to pay the full
difference between the predetermined employer payment and the plan’s actual
premium.56  The more common pattern for employers offering multiple health
plans, however, is to require employee contributions reflecting only part of the
cost differences among them.  Another popular approach has been to offer
employees a single plan of the “point-of-service” variety.  Such plans charge
everyone the same premium for access to the plan’s limited provider network,
but then allow individuals to elect care from non-network providers at a
substantial additional cost.  In these plans, lower-income persons have the
option of staying within the system, thus enjoying some savings.
Although structuring employee benefits in any of the foregoing ways allows
employees desiring somewhat cheaper coverage to have it, none of these
approaches leaves consumers with either strong incentives to economize
beyond a certain arbitrary point or reasonable opportunities for doing so.  Even
in fixed-contribution plans, employers are likely to set their contributions at a
relatively high level, because only the employer-paid portion of the premium
enjoys the favorable tax treatment that better-paid employees especially covet.
Moreover, even though one or more plans offered by an employer might be
significantly cheaper than others, all plans (including point-of-service ones)
feature the same nominal entitlement within each category of coverage—a right
54. See id. at 100-03.  Even with tax subsidies inflating demand for comprehensive (even first-
dollar) coverage, however, reliance on market forces is not an implausible policy.  Id. at 102 (observing
that even very heavy tax subsidies encouraging investment in personal residences have not disabled the
market for housing).
55. See generally Alain C. Enthoven, Commentary—The Fortune 500 Model for Health Care: Is
Now the Time to Change?, 27 J. HEALTH POL. POL’Y & L. 37 (2002).
56. Id. at 45.
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to receive all “medically necessary” care meeting professional standards, as
determined and enforced by courts.57  The cost differences among them
therefore reflect, not explicit qualitative differences in the care underwritten or
provided, but only different categorical exclusions, different cost-sharing
requirements, different physician networks, different coverage of out-of-
network care, and so forth.  Unless and until a critical mass of employers offer
benefits in forms that invite real economizing at the core of clinical practice,
consumers whose welfare would be enhanced by purchasing revolutionary low-
cost coverage will find no health plans offering it.
Alain Enthoven has bemoaned how few employers today offer their
employees a range of health care choices with appropriate price tags attached.58
He has also noted employers’ expedient reasons for their various practices.  In
part, however, the impulse of most employers to give all their employees access
to care meeting the same qualitative standard probably reflects a felt need to
preserve egalitarian appearances.  Although employers feel comfortable in
offering alternative plans featuring different cost sharing or different limits on a
patient’s freedom to choose a provider, most would quickly reject the idea of
offering, as an option that some employees might feel compelled to choose, a
plan with substantive entitlements explicitly inferior to those preferred by
better-off employees.  Thus, even though employees today may have some
range of choice, they are deprived of options that many of them might prefer.
To be sure, how far the choices available to today’s consumers fall short of
meeting their personal needs is an unanswerable empirical question.  The
health care revolution, however, has not succeeded in giving them anything
approaching the same control over their spending for health care that they have
over other expenditures they make.  Thus, health care is still rather far from
being a true consumer good on which consumers can reasonably economize
when times are bad or when other needs predominate.
B. The Difficulty of Customizing Health Care Contracts
Another reason why explicit qualitative differences have not appeared in
the market for health care and health coverage may be the difficulty health
plans would face in trying to articulate in administrable contract language any
standard other than the dominant professional one.59  The product a health plan
57. See infra notes 59-69 and accompanying text.  “Medical necessity” is the standard universally
employed in determining patient entitlements.  Obviously derived from the any-benefit-is-worth-
paying-for principle embodied in the professional paradigm, it is generally applied in practice by refer-
ence to professional standards.  See generally SARA SINGER ET AL., CENTER FOR HEALTH POLICY,
STANFORD UNIVERSITY, DECREASING VARIATION IN MEDICAL NECESSITY DECISION MAKING
(1999); Linda A. Bergthold, Medical Necessity: Do We Need It?, HEALTH AFF., Winter 1995, at 180.  A
criticism of its universal use can be found in HAVIGHURST, HEALTH CARE CHOICES, supra note 3, at
143-47.
58. Enthoven, supra note 55.
59. This was a better excuse in the early days of health insurance than it is today:
Although adopting professional standards by reference was once an efficient way to write
health care contracts, the universal use of contracts written in this way eventually created a
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sells is, after all, entirely intangible—only a contractual undertaking to deliver
(or finance) certain health services (of a particular quality) under certain
contingencies.  A health plan could offer economical alternative coverage,
therefore, only by explicitly contracting with its subscribers in ways that
effectively limit both its own payment obligations and the legal duties of its
providers.  Whereas ordinary commercial contracts for the future delivery of
goods or services generally incorporate detailed specifications of the
deliverables, it would be very difficult to write a health care contract effectively
specifying the obligations of the plan and its providers under all the
circumstances that might arise.60  Whether for this reason or others, post-
revolutionary health plans still define most of their own and their providers’
obligations only by reference to professional standards.61
The drafting problem, however, is not the only or even the principal reason
why health care contracts have not been written to give consumers significant
economizing options.62  A greater obstacle to the offering of low-cost health care
has been the U.S. legal system.63  Even as national health policy seemed to be
entrusting choices to consumers and their agents, no one thought to instruct the
courts to replace the old professional paradigm of medical care with a new
paradigm based on consumer choice and private contract.64  It thus remains
market without elementary financial constraints on the proliferation of new medical
technologies and the evolution of professional standards.  Not only did medical care become
stunningly expensive under the incentives thus created, but the law’s compulsions, derived
from customary practice, increasingly lost touch with economic rationality.  Ironically,
contracting methods that were arguably in the consumer’s interest when they were first
adopted ultimately undercut the utility of health care contracts as tools for cost containment.
There is good reason, therefore, for contract drafters to reconsider their long-standing
convention of letting the medical profession and the courts finally define payer and provider
obligations.
HAVIGHURST, HEALTH CARE CHOICES, supra note 3, at 117.
60. Incomplete or ambiguous contracts would not, however, be unique to health care.  See gener-
ally David Charny, Hypothetical Bargains: The Normative Structure of Contract Interpretation, 89 MICH.
L. REV. 1815 (1991).  A possible solution in the health care context would be a fully articulated set of
procedures for consistently administering the contract, subject to judicial review only for abuse of dis-
cretion.  See, e.g., HAVIGHURST, HEALTH CARE CHOICES, supra note 3, at 200-14; see also infra note
118.
61. Although some things such as cosmetic surgery or “experimental” treatments are typically
excluded from coverage categorically, outside these excluded categories, health care contracts generally
cover all services deemed “medically necessary.”  See supra note 57.
62. For suggestions on how better contracts might be written, see HAVIGHURST, HEALTH CARE
CHOICES, supra note 3, at 157-221.  See also infra Part VII.
63. See generally Havinghurst, Health Care Choices supra note 3, at 303-30; Mark A. Hall &
Gerald F. Anderson, Health Insurers’ Assessment of Medical Necessity, 140 U. PA. L. REV. 1637 (1992);
Clark C. Havighurst, Prospective Self-Denial: Can Consumers Contract Today to Accept Health Care
Rationing Tomorrow?, 140 U. PA. L. REV. 1755 (1992).
64. But see Clark C. Havighurst, Decentralizing Decision Making: Private Contract versus Profes-
sional Norms, in MARKET REFORMS IN HEALTH CARE: CURRENT ISSUES, NEW DIRECTIONS,
STRATEGIC DECISIONS 22 (Jack A. Meyer ed., 1983).  In this early article about the emerging revolu-
tionary challenge to “the prevalent assumption that the health care system must operate under pre-
scriptive standards of acceptable care and appropriate spending,” id., I warned would-be market
reformers of the health care system, who were then in a somewhat triumphant mood, that they “could
go wrong . . . by assuming too readily that interacting private parties and institutions would be free and
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conventional today, just as it was before the antitrust revolution, for courts to
look solely to consensus and custom in the medical community to find the
standards they use in judging medical negligence or in defining the obligation of
a health plan to pay for physician-prescribed services.65  Although this source of
benchmarks is regularly incorporated in private contracts, either by implication
(as in the typical, unwritten physician/patient contract) or by explicit reference
(as in the common commitment to cover all “medically necessary” services), the
universal acceptance of professional standards is in no sense voluntary.  Health
plans have simply been unable to rely on courts to enforce, or to enforce
according to its intended terms, any contract purporting to set any standard
other than a professional one.66  Although drafting an alternative standard
would certainly be difficult, it would be still harder to get courts consistently
and routinely to allow contractually authorized departures from professionally
dictated norms.  Without freedom of contract as a safety valve to release the
pressure on providers and plans to provide only high-cost, conventional care,
the legal system stands as a major obstacle to empowering consumers and
completing the health care revolution.
The legal system’s unshakable attachment to professional standards is ironic
in light of the evidence that much conventional medical practice lacks a solid
scientific foundation.67  In addition, because professional standards have evolved
with little need to compare health benefits and economic costs, they have no
presumptive claim to represent either efficient practice or sound public policy.
Nor have they ever been explicitly adopted as binding regulatory standards
through the democratic political process.  Instead, the common law system has
simply embraced the medical profession’s preferred paradigm of medical care,
uninhibited in their competitive efforts to translate consumer cost concerns into economizing behavior
by providers”  Id.  Expanding on ideas first expressed by Richard A. Epstein, Medical Malpractice: The
Case for Contract, 1 AM. B. FOUND. RES. J. 94 (1976), the article raised doubt about the flexibility and
utility of private contracts as vehicles for introducing alternative standards, rights, and obligations in
the health care field.  As I feared, the need to ensure freedom of contract was indeed below the radar
of policy-makers, whose main concern in deregulating the health care sector was only to roll back
explicit command-and-control regulation.  Yet, as I observed,
[d]octrines of private law—the law of torts and contracts—may impose on private parties
duties that are inconsistent with both efficiency and the parties’ contractually specified
obligations.  If such legal doctrines, originally designed to prevent economically powerful
interests from overreaching the consumer, stand in the way of departures from prevailing
standards of care and practice in the medical care field, market reformers’ hopes of seeing
consumers offered a full range of choice are doomed to frustration.
Havighurst, supra, at 23 (emphasis added).  It is ironic that legal doctrines ostensibly designed to pro-
tect consumers against “economically powerful interests” so effectively turned back the health care
revolution’s move to enable consumers to contest the powerful dictates of both law and medicine,
thereby perpetuating “The Tyranny of Professional Norms and Standards.”  Id.
65. For observations and materials relating to professional standards as (costly) legal standards, see
CLARK C. HAVIGHURST ET AL., HEALTH CARE LAW AND POLICY: READINGS, NOTES, AND
QUESTIONS 191-204, 999-1070, 1228-38 (2d ed. 1998) (examining both malpractice law and coverage
issues).  See also HAVIGHURST, HEALTH CARE CHOICES, supra note 3, at 111-17.
66. See generally Hall & Anderson, supra note 63; HAVIGHURST, HEALTH CARE CHOICES, supra
note 3, at 304-30.
67. See supra notes 23-25 and accompanying text.
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which insists on treating all clinical choices as purely technical ones and denies
the legitimacy of balancing benefits and costs.68  Indeed, although physicians
regularly malign the legal system in the United States, it has remained their best
defense against revolutionary forces threatening to lessen both their standard-
setting authority and general demand for their costly services.  By unthinkingly
giving normative effect to professional standards as more than default rules
escapable by contract, the law has prevented the health care revolution from
liberating consumers from the dictates of a professional monopoly.69
V
HEALTH PLANS’ FAILURE TO EARN CONSUMERS’ TRUST
A third way in which the health care revolution failed to achieve its
democratic objectives was in not giving consumers new representatives whom
they could trust to execute their wishes.  Even though early proponents of
HMOs and other reforms envisioned that health plans would be valuable allies
of consumers in battling high health care costs and entrenched professional
power, the political backlash against managed care in the 1990s revealed that
the health care revolution never gained favor among the ordinary citizens
whom it was supposed to benefit.  Indeed, today’s consumers/voters seem quite
ready to see their health plans put under new regulatory constraints and new
threats of legal action.70  An important question is why health plans, newly
empowered by the revolution of the late 1970s, never gained enough public
trust to carry out crucial elements of their mission in a market-driven health
system.
In part, the problem was that health plans achieved commercial success too
easily in the 1980s.  Thus, they were able to earn high profits, not by reforming
themselves or the health care system in accordance with revolutionary
68. See supra notes 8, 63-65; see also Helling v. Carey, 519 P.2d 981 (Wash. 1974).  In the latter
famous case, the Washington Supreme Court rejected a customary standard of care that reflected
actual market choices by cost-conscious consumers (of routine eye exams, a service not widely covered
by insurance) and required instead that, whatever the added cost, ophthalmologists must adhere to the
standard generally prevailing for insured services, where moral hazard operates and cost is no object.
Thus, under Helling, if a service might yield a benefit to the patient, it is negligent for the physician to
omit it.
69. “It is simply ironic that the same legal system that with one arm launched an antitrust initiative
successfully challenging overt efforts by the medical profession to exercise decision-making authority
has with its other arms given medical interests a monopoly over the most important economic decisions
affecting American health care.”  Clark C. Havighurst, American Health Care and the Law—We Need
to Talk!, HEALTH AFF., July/Aug. 2000, at 84, 97.
70. See Robert J. Blendon et al., Understanding the Managed Care Backlash, HEALTH AFF.,
Jul./Aug. 1998, at 80 (reporting public dissatisfaction with managed care in general, despite overall sat-
isfaction with their own plans).  Findings such as those reported by Blendon and his colleagues suggest
that political support for patient protection legislation, while seemingly wide, is not as strong as the
media make it appear.  See also Fred Barnes, Patients’ Bill of Goods, WEEKLY STANDARD, Aug. 6,
2001, at 11 (reviewing polling data).  It is notable in this context that Congress has been more eager to
entertain legislative proposals than to pass them, perhaps because supporters find the issue a good one
on which to posture and because both sides find it a lucrative source of campaign contributions.  On the
prospects for such legislation in 2002, see Havighurst, supra note 1, at 3-4 n.12.
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principles, but simply by negotiating lower payments to providers, selecting
only better risks (healthier enrollees) in forming risk pools, and discouraging
expenditures that were wasteful by any standard.  With pickings so easy, there
was no need for health plans to essay significant innovation in organizing
providers, in educating consumers concerning the benefits of new
arrangements, or in writing heretical contracts.  In addition, consumers could
not see HMOs’ vaunted accomplishments.  Reported cost savings, for example,
appeared to accrue only to employers, plan shareholders, or well-paid CEOs—
even when they were in fact passed on, unlabeled (and therefore taken for
granted), in higher take-home pay.  Consumers also looked largely in vain for
quality improvements and for increased responsiveness to their own concerns.
Because their early success came so easily, health plans failed to lay a
foundation, or to prepare consumers, for a future when cost savings would
come harder and be more controversial.
Politically, too, the managed care industry took the easy path and failed to
build constituencies that would support it against counter-revolutionary forces.
Taking their cues mostly from employers (their immediate customers) and from
the friendly political environment of the 1980s, managed care firms saw no need
to cultivate the understanding and confidence of ordinary consumers.  Their
message, like that of the medical profession in an earlier era, was essentially,
“trust us”—which the public ultimately refused to do.  Without solid consumer
support, managed care plans proved to be political pushovers as soon as the
public began to scrutinize their manner of doing business.  And politicians
proved fickle as soon as public opinion turned sour.  The goodwill that managed
care firms initially enjoyed without having to earn, and then arguably
squandered, will be difficult to regain.
Mistrust of the managed care industry among influential opinion-makers
was inspired in large part by health plans’ insulation from normal legal
accountability for injuries their erroneous decisions might cause to patients.
The federal Employee Retirement Income Security Act of 1974 (“ERISA”)71
was construed to preempt both state regulation and state legal remedies against
health benefit plans maintained by private employers.72  Therefore, because
federal law, including ERISA itself, provided only weak protections and
remedies, managed care plans were left free to pursue their cost-containment
71. 29 U.S.C. § 1001 (2000).
72. Ingersoll-Rand Co. v. McLendon, 498 U.S. 133, 142 (1990) (citing Congress’s goals of
“ensur[ing] that plans and plan sponsors would be subject to a uniform body of benefits law” and
“minimiz[ing] the administrative and financial burden of complying with conflicting directives among
States or between States and the Federal Government”); Pilot Life Ins. Co. v. Dedeaux, 481 U.S. 41,
47-48 (1987) (holding that common law tort and contract causes of action seeking damages for
employer’s disability insurer’s improper processing of a claim are preempted by ERISA); Bast v. Pru-
dential Ins. Co. of America, 150 F.3d 1003 (9th Cir. 1998) (holding that ERISA preempted patients’
survivor claims for denial of coverage for autologous bone marrow transplant and related treatment);
Corcoran v. United Healthcare, Inc., 965 F.2d 1321 (5th Cir. 1992) (holding claim against employer-
retained benefits manager preempted by ERISA). This effect of ERISA was wholly unanticipated by
Congress.  See infra note 74.
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agendas without much risk of liability to angry patients.73  In some respects,
ERISA advanced the agenda of the health care revolution by allowing self-
insured employers and firms administering employee benefits to undertake
innovations in cost containment without permission from conservative state
insurance regulators and without facing other legal risks.74  But health plans’
success in bringing themselves within ERISA’s protections also made them
susceptible to valid criticism and successful political attacks, eventually turning
what appeared to be a legislative blessing into a political curse.  If ERISA had
not insulated health plans from damage claims when they misuse their power to
ration financing, health plans might have been more candid in explaining
themselves to consumers and more careful in crafting their contracts.
In retrospect, it seems that health plans could have avoided many of their
recent political problems if they had built their defenses on the merits—in the
marketplace and in their contracts with consumers—rather than on the unstable
sands of early political popularity, employer support, and ERISA preemption.75
To be sure, managed care plans could never have carried out the revolutionary
agenda in full as long as consumers were effectively shielded from seeing
(though not from paying) much of the cost of their own health care.  But the
purveyors of managed care made many mistakes in designing and marketing
their products.  Instead of building on the revolution’s premises, managed care
plans proceeded on the assumption that, because they had been endorsed by
employers and policy-makers, their methods constituted, and would be viewed
as, the wave of the future.76  On this basis, they confidently curtailed consumers’
traditional entitlements without such niceties as adequate disclosure of their
business methods or contracts authorizing their use.77  Although the methods
73. See generally Peter Jacobson & Scott Pomfret, Form, Function, and Managed Care Torts:
Achieving Fairness and Equity in ERISA Jurisprudence, 35 HOUS. L. REV. 985 (1998).
74. Ironically, ERISA was not meant to be part of any revolutionary agenda in health care, for it
was enacted well before the market option was recognized as a plausible reform strategy.  Moreover,
Congress passed it to reform the management of pension funds, not health care.  Before ERISA,
employers generally provided health coverage through conventional insurance, the state regulation of
which ERISA’s so-called “saving clause” specifically excepted from its preemptive reach.  29 U.S.C.A.
§ 1144(b)(2) (2000).  Unintended consequences resulted, however, when most employers large enough
to do so began to self-insure their employees’ health benefits, thus escaping both the burdens of state
insurance regulation and the impact of other state laws applicable to health insurers.  In addition, the
Supreme Court added to ERISA’s preemptive scope by permitting free-standing health plans such as
HMOs (as well as self-funded employer plans) to invoke preemption when they were administering
employer-purchased benefits.  See Pilot Life, 481 U.S. at 47-48 (recognizing “no dispute” that—and
stating that “undoubtedly”—an employer’s independent disability insurer could invoke ERISA pre-
emption unless the saving clause applied).  Only recently has the saving clause been construed broadly
enough to restore most of the states’ regulatory authority over such plans.  Rush Prudential HMO, Inc.
v. Moran, 122 S. Ct. 2151 (2002).  See note 125 infra.
75. See generally Havighurst, supra note 41 (finding possible merit in consumer class actions alleg-
ing nondisclosure, misrepresentation, and fiduciary breaches by HMOs in presenting themselves to
consumers).
76. See Havighurst, supra note 1, at 6-7 n.18.
77. Robinson, supra note 28, at 2623 (“[T]he fundamental flaw of managed care, in retrospect, was
that it sought to navigate the tensions between limited resources and unlimited expectations without
explaining exactly how it was so doing.”).
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they employed were generally accepted in policy circles, they were bound to be
misunderstood by the general public if not carefully explained in advance.78
Nevertheless, consumers were never told that there are trade-offs in health care
(as in the rest of life), or that low premiums (and higher take-home pay) depend
on preventing individual providers and patients from drawing too freely on the
premium pool.  Instead, consumers were encouraged to believe that nothing
important had changed in their legal entitlements or in their relationships with
physicians.79
It is at least possible that health plans could have avoided extreme public
mistrust if they had approached consumers honestly and as sovereign decision
makers—in the democratic spirit of the health care revolution.  Legitimacy in
the public eye might have been achieved by offering consumers clear choices
among well-explained alternatives bearing price tags roughly reflecting their
qualitative differences.  Reasonable agreements entered into ex ante might
therefore have been easier to enforce when regrets arose ex post.  And well-
crafted contracts might have provided legal warrants for cost-control measures
that are entirely defensible as responses to moral hazard, but hard to defend
under the populist-cum-professional view of health care held by all plaintiffs’
lawyers and, apparently, by most journalists, politicians, physicians, judges, and
juries.  In any event, because the health care revolution failed to produce a new
regime of trustworthy decision-makers, it was relatively easy for revanchist
interests to preserve or restore essential elements of the old order.
VI
WHY THE REVOLUTION NEVER HAD A CHANCE:
THE POLITICAL ECONOMY OF HEALTH CARE LAW AND POLICY
Modern health plans are only partly responsible for the shortfalls of the
health care revolution, since most of their failings reflected cultural, economic,
regulatory, and legal conditions that they could neither ignore nor easily
change.  Thus, health plans’ public relations and marketing appeals had to
recognize the extent to which consumers, insulated from health care costs,
wanted only soothing promises, not opportunities to economize by accepting
apparent health risks.  In addition, on advice of counsel, health plans
undoubtedly felt legally bound to finance all care meeting professional
standards rather than acting as surrogate economizers for their subscribers.
Indeed, the legal system, after initiating antitrust enforcement in the 1970s,
never embraced the cognate market principle that consumers should be free to
make potentially consequential choices about their own health care.  As a
result, the United States never really came close to forging the chain of public
78. Id. at 2627 (“The strategy of giving with one hand while taking away with the other, of offering
consumers comprehensive benefits while restricting access through utilization review, obfuscates the
workings of the system, undermines trust between patients and physicians, and has infuriated everyone
involved.”).
79. See generally Havighurst, supra note 41, at 14-21.
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policies necessary to empower consumers to purchase health care according to
their respective needs and circumstances.80
This section of the article explains the legal and political consensus that
strongly supports prescriptive regulation of health care and the systematic
hiding of health care costs from those who pay them.  This explanation is
necessary to complete the article’s assessment of why, despite the hopes of
some early visionaries, no real revolution ever occurred in American health
care.
A. The Crucial Moral Hazard
The conventional justification for imposing heavy doses of judge-made law
and regulation on the health care sector is the inability of consumers to gauge
the quality of care, which may make it impossible for a free market in health
services to produce efficient results.81  Notwithstanding the availability of
middleman-agents who could supply much of the sophistication that individual
consumers inevitably lack, the political/legal culture is powerfully committed to
this market-failure rationale for not letting ordinary people face trade-offs
between cost and quality.  Significantly, however, neither government nor the
legal system has stepped into consumers’ shoes and accepted responsibility for
making better-informed economic choices about health care on their behalf.  To
the contrary, law and public policy still embody the medical profession’s
preferred paradigm of health care, under which cost considerations are largely
excluded from all judgments except insofar as the profession itself may
recognize their relevance.  The market-failure rationale is thus less of a
justification for limiting freedom of contract than a pretext for keeping ultimate
authority in professional hands—medical or legal, as the case may be.
On reflection, it should be obvious that the market failure most responsible
for economic inefficiency in the health care sector is not consumers’ ignorance
about the quality of care, but rather their ignorance of the cost of care, which
ensures that neither the choices they make in the marketplace nor the opinions
they express in the political process reveal their true preferences.  Virtually
everyone involved in the never-never land of health care thinks—rightly in
some cases, wrongly in others—that someone else will pay the bill, including
whatever costs law and legislation may impose.  Consumers believe that most of
the cost of health care, beyond the fraction they may see as their own
contribution, is borne by their employers, rich insurance companies, or the
government.  On the other hand, employers know differently—that, although
they may write the checks for coverage, cost increases are ultimately borne
80. See supra notes 64, 69.
81. See, e.g., Kenneth J. Arrow, Uncertainty and the Welfare Economics of Medical Care, 53 AM.
ECON.  REV. 941, 951-52, 965-67 (1963); Russell Korobkin, The Efficiency of Managed Care “Patient
Protection Laws”: Incomplete Contracts, Bounded Rationality, and Market Failure, 85 CORNELL L.
REV. 1 (1999).
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mostly by the employees themselves in the form of lower wages.82  Insurers and
health plans, for their part, know they can charge greater premiums to cover
any higher costs that regulation entails as long as their competitors face similar
increases; indeed, demand for coverage may be so price-inelastic that new
regulations will actually increase their revenues even though some current
customers are forced to drop or reduce coverage.  Legislators know that, except
in maintaining public financing programs, they do not have to levy taxes to pay
the cost of complying with regulatory mandates they impose on health plans;83
they can also expect that more voters will praise them for imposing high
standards than will penalize them for the cost increases that such standards
entail.  Judges and juries, of course, are even less accountable for costs they
cause the health care industry to incur and consumers to pay.
The consequence of the shell game in which costs are moved wherever
employees/consumers/voters are not looking is that medical practice and health
care plans are pervasively overregulated in the United States—that is, subject to
legal prescriptions that make sense only because price tags have been generally
removed.  Several whole percentage points of the nation’s gross domestic
product (“GDP”) are thus diverted wastefully to health care from other uses.
The problem is not, as widely believed, the additional spending that results
from the moral hazard inherent in any insurance scheme.  Even though moral
hazard operates with particular vengeance in health insurance, it can be
managed to some extent, and its remaining costs may be entirely acceptable as a
necessary cost of the valuable financial protection that insurance provides.84
Inefficiency occurs, however, as soon as government or the legal system barges
in to preclude financing intermediaries from effectively managing care—that is,
from taking administrative and other actions to limit the impact of moral
hazard—or requires them to honor costly entitlements prescribed by law or
professional standards rather than set forth in freely negotiated contracts.
Indeed, the only moral hazard currently causing major inefficiency in the health
care sector is the one that operates when employers, government, or the legal
system write prescriptions for which consumers must pay.  Aggregate welfare is
less than it might be because the nation spends vast sums on services that no
82. Linda J. Blumberg, Who Pays for Employer-Sponsored Health Insurance?, HEALTH AFF.,
Nov./Dec. 1999, at 58.  To be sure, employers can expect complaints if they reduce coverage or ask
employees to pay more for it out-of-pocket.  They may therefore prefer to impose some of the increas-
ing cost of coverage on employees by holding down their take-home pay.  Indeed, employers’ need to
maintain flexibility in passing on predictable increases in health premiums may explain much of their
reluctance to shift to a fixed-contribution approach to providing health coverage.  See Enthoven, supra
note 55, at 41 (“[H]ealth insurance [is] usually the responsibility of human resources departments
whose mission is to keep employees happy, not to rock the boat in ways that might make some
unhappy.”).
83. Pending federal patient protection legislation, see infra notes 115-121 and accompanying text,
may or may not include, if and when enacted, a provision extending its protections to federal employ-
ees, for whom Congress bears much of the cost of coverage.  See Stephen Barr, Amendment to Patients’
Rights Bill Riles Large Federal Health Plans, WASH. POST, July 15, 2001, at C2.
84. See HAVIGHURST, HEALTH CARE CHOICES, supra note 3, at 96-100 (“[S]ome overconsump-
tion is an inevitable, and therefore tolerable, part of the cost of pooling financial risks.”).
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one, neither consumers, nor health plans, nor government, has reckoned are
actually worth what they actually cost.
Despite the importance of allocative efficiency as a desideratum in
economic theory, most health economists seem untroubled by the apparent
misallocation of excessive resources to health care in the United States.85
Perhaps this is because economists are generally taught that allocative
inefficiency is mostly a technical problem, not a serious policy concern.86  Even
monopoly, they learn, although causing too little productive capacity to be
allocated to producing the monopolized good, results in surprisingly little
“dead-weight loss” to the overall economy.87  One reason why economists might
deprecate allocative efficiency as a policy goal is the so-called “problem of
second-best,” which suggests that, because there are so many other distortions
in the economy, one more distortion is unlikely to make things appreciably
worse.88  On this basis, and also because health care employs many people and
yields a vast amount of consumer surplus (in the aggregate, if not at the
margin), an economist might not view the over-allocation of resources to health
care as a problem that should trouble policymakers.89
85. ENTHOVEN, supra note 3, at 11-30 (observing neglect of allocative efficiency in health policy).
But see Korobkin, supra note 81, at 31 (seemingly opining that health care is being underproduced in
the United States as a result of market failures that allow managed care plans to systematically econo-
mize at the expense of quality, justifying additional patient-protection regulation, but actually proving,
at best, only that care might be underproduced in a totally free market without significant public subsi-
dies).
86. Cf. Joel Waldfogel, The Deadweight Loss of Christmas, 83 AM. ECON. REV. 1328 (1993) (ques-
tioning the efficiency, though not the practice, of letting even well-intentioned people make consump-
tion decisions for others).
87. See, e.g., F.M. SCHERER & DAVID ROSS, INDUSTRIAL MARKET STRUCTURE AND ECONOMIC
PERFORMANCE 667 (3d ed. 1990) (“[I]t appears that the dead-weight welfare loss attributable to
monopolistic resource misallocation in the United States lies somewhere between 0.5 and 2 percent of
gross national product.”).
88. See, e.g., id. at 38 (“[O]ne might conclude that the whole question of allocative efficiency is so
confused and uncertain, once second-best considerations are introduced, that policy-makers would be
well advised to give up trying to achieve the best possible allocation of resources.”).
89. For an illustration of the sanguine attitude of health economists toward the possibility that
large increments of GDP are flowing into the provision of health care without anyone’s consent and
without any other assurance that substantial resources are not being wasted at the margin, see David
M. Cutler & Mark McClellan, Is Technological Change in Medicine Worth It?, HEALTH AFF., Sept.-
Oct. 2001, at 11.  This study examines five new technologies and concludes (under the assumption
drawn from “the literature” that additional healthy years of life are each worth $100,000) that “medical
spending as a whole is clearly worth the cost.”  This conclusion amounts to nothing more than a finding
that health care in general yields positive consumer surplus—hardly a surprise, since life-saving, when it
occurs, has high value.  On the other hand, it begs the much more important question of whether there
is avoidable waste in some incremental spending.  A particularly revealing feature of the Cutler-
McClellan study is their valuation of neonatal care by valuing every year of healthy life that health care
makes possible at $100,000 each.  Even discounting to present value, this method of making social
judgments provides an irresistible warrant for extremely costly efforts to save even very low-birth-
weight newborns, even though rational individuals might prefer to save money for other uses by pur-
chasing coverage that excludes this and other similarly heroic measures.  In effect, government and the
American legal system, aided and abetted by academic apologists, have stepped into the paternalistic
shoes of earlier provider cartels to deny consumers the freedom to decide for themselves the extent to
HAVIGHURST_FMT.DOC 10/23/02  1:50 PM
Page 55: Autumn 2002] HOW THE REVOLUTION FELL SHORT 81
But even if allocative problems created by monopolistic overcharges in a
few industries are trivial, it does not follow that the over-consumption induced
by shielding consumers from most of the cost of both health care and health
coverage is also of trivial concern.  For one thing, second-best theorizing—
which suggests that eliminating monopoly in a given market will not necessarily
improve resource allocation, because monopoly, taxes, and regulation cause
many other goods and services also to be priced in excess of marginal costs and
thus to be consumed at less than optimal rates—is a powerful reason for taking
especially seriously, rather than discounting, the misallocative tendency of
pricing health care below marginal cost and subsidizing it in ways unrelated to
securing basic social justice.  More generally, it is facially troublesome that
health care spending represents one-seventh of GDP in the United States (even
without providing fully for a huge segment of the population) while accounting
for only a ninth of GDP or less in all other developed nations.90  Finally, looking
beyond the matter of the efficiency of the overall economy, it appears that the
cost of providing excessive health care in the United States falls
disproportionately on the shoulders of lower- and middle-income premium
payers, forcing them to allocate their own limited resources in ways they might
deem adverse to their individual welfare.91  The remainder of this part of the
article dramatizes the allocational problem in terms of this last observation.
From the foregoing, it is apparent that the moral hazard that matters most in
health care results from the insulation of consumers qua consumers from the
cost of their health coverage, enabling employers and the political/legal system
which their incomes should be spent on what they might consider to be marginally productive medical
care.
90. See Gerard Anderson & Peter S. Hussey, Comparing Health System Performance in OECD
Countries, HEALTH AFF., May/June 2001, at 219, 227-28.
91. Although conventional thinking excuses taking significant choices away from people on the
ground that they cannot evaluate health services, I know of no evidence clearly supporting the assump-
tion that ordinary people will generally, in their ignorance, make choices that undervalue health care.
The evidence most often cited is that consumers seem to choose health plans with price as the principal
determinant, apparently ignoring the quality dimension.  See Korobkin, supra note 81, at 56-59.  But
this tendency may signify only that, due to law and regulation narrowly prescribing the choices they are
offered, today’s consumers are operating at a margin where they see little risk of getting poorer quality
than they are willing to pay for (and, consequently, feel safe in economizing as much as the system
permits).  To be sure, there is evidence that individuals consistently underestimate the health risks they
face, for example, Neil Weinstein, Unrealistic Optimism About Susceptibility to Health Problems: Con-
clusions from a Community-wide Sample, 10 J. BEHAV. MED. 481 (1987), and it is therefore possible
that ex ante choices about health coverage might reflect undue risk-taking.  But everyone must antici-
pate a need for health services in the future, and at least some people, offered real health care choices
and feeling uncertain and conflicted about the implicit trade-offs they are being asked to make, might
be risk-averse, erring on the side of overspending rather than underspending.  In any event, regulation
will inevitably preclude many risky choices, and public subsidies can be designed to ensure that con-
sumers will not economize in ways that expose them to undue risk.  Thus, notwithstanding sophisticated
analyses such as the extensive one offered by Korobkin, supra, note 81, there is no strong reason (other
than analysts’ assumption that everyone should choose the highest-quality care available, just as they
would) to think that consumers cannot be trusted to choose for themselves among the options avail-
able.  “Bounded rationality” is a fact of life, but it need not always be an excuse to turn consequential
choices over to political decision-makers or judges who lack any incentive to ensure that consumers’
money is spent as consumers themselves would rationally spend it.
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to take costly actions without having to account to employees/consumers/voters
for their full costs.  Unlike many other market failures warranting government
interference in the economy, the moral hazard created by the hiding of health
care costs is not inherent in the nature of health care or the marketplace.
Instead, it is a consequence of policies consciously adopted by employers and
government in subsidizing access to health care for employed individuals.  For a
variety of reasons, most employers eschew making fixed contributions for each
employee to finance health benefits of their own choosing, even though that
strategy would cause employees to make cost-conscious choices at the margin.92
On the other hand, government tax subsidies have no upper limit and thus
dilute employers’ sensitivity to the marginal price differences they face on their
employees’ behalf.  The form of tax subsidies also allows employers to allocate
substantial portions of their workers’ incomes sub rosa to advance interests of
their own—by artificially cultivating employee good will, for example, or
attracting high-level employees.
The interesting question, to be examined below, is why subsidies for the
purchase of health services continue to be provided in a form universally
disapproved of by policy experts, both for regressivity and for distorting
spending decisions.  In other words, why do employers and government persist
in following policies that exacerbate moral hazard not only in private
consumption decisions but in public regulatory ones as well?  This question
prompts one to look for potent interest groups with a stake in systematically
keeping health care costs hidden from the consumers/voters/employees who
ultimately pay them.  Obviously, most components of the health care industry
itself prefer costs to be hidden and uncounted.  But there may be others, too,
with an interest in seeing that health care costs are borne by society in such a
way that few occasions exist for comparing marginal costs and benefits, thus
ensuring maximum funding for the health care enterprise.
B. Who Gains?  Who Loses?
It is possible to illustrate graphically how consumers’ ignorance about the
incidence of health care costs, together with more widely recognized defects in
the political process, induces the setting of especially inefficient regulatory and
legal standards for health care and health plans.93  In Figure 1, a bell curve
92. See Enthoven, supra note 55.
93. For an earlier iteration of this model, see Havighurst, Backlash, supra note 10, at 401-08.  As an
exercise in “public-choice” theorizing, the model owes as much to concerns about the excesses of
majoritarian politics as to cynicism based on the undue influence allegedly exercised by powerful, well-
organized special interests.  Indeed, I believe I have identified an instance in which the twin banes of
political democracy—the power of political majorities to exploit minorities and the ability of rent-
seeking special interests to victimize an ignorant or inattentive majority—operate in tandem to doubly
bad effect.  The story I tell can only disappoint scholars seeking to redeem democratic government’s
regulatory initiatives by arguing that voters and well-meaning politicians frequently transcend self-
interest and pursue the larger public interest even when theory predicts differently.  See generally
Symposium, Getting Beyond Cynicism: New Theories of the Regulatory State, 87 CORNELL L. REV. 267
(2002).  Although the regulation of managed health care might appear to be an instance in which altru-
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represents the distribution of consumer demand for a hypothetical good or
service that is available in both low-cost, low-quality versions (to the left) and
high-cost, high-quality versions (to the right).  To protect consumers against
harms they might suffer from mistakenly purchasing poor quality, the
government might intervene with regulation to preclude sellers from offering
goods below a certain standard—say, point o in Figure 1.  In theory, a
regulatory line drawn at point o might be in the overall public interest even
though it denies some individuals, mostly lower-income ones, their first choices
and forces them to pay more than they would prefer to spend.94  Not only might
such regulation spare the latter individuals the cost of injuries they might suffer
from taking unrecognized or unwise risks, but other consumers, now having less
reason to worry about buying very poor quality health care, could spend less
time and other resources searching the market.
FIGURE 1:
REGULATING QUALITY
ism dominates, my analysis suggests that things have been rigged to dupe ordinary people into consis-
tently voting against their true self-interest, thereby benefitting both industry interests and the upper
middle class.
94. The result would be efficient in the “Kaldor-Hicks” sense, meaning that it is enough that gains
to winners exceed losses to losers, even if the former do not have to compensate the latter.  See
RICHARD A. POSNER, ECONOMIC ANALYSIS OF LAW 13-15 (5th ed. 1998).  That the costs of regula-
tion fall mostly on lower-income persons does not affect the conclusion that regulation is efficient.
#
o OR HR QL
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But even though a degree of regulation might be justified under such a
calculus, prescriptive regulation in a majoritarian world could easily impose
costs on the low-income minority that substantially exceed any gains to the
larger society.  Particularly where the good or service being regulated
potentially contributes to improved health or safety,95 one must consider the
extent to which the higher prices prevailing under regulation cause some
consumers to forgo purchasing the regulated good or service altogether.  When
inflated prices have this effect, substantial injuries could result, and should be
counted among the costs of regulation.96  It is not enough that regulation raises
the overall value of services actually provided; it must also not lower aggregate
welfare by denying valuable services to even a small minority.
Unfortunately, the dynamics of the political market for consumer-protection
regulation provide strong reasons to believe not only that standard-setting,
command-and-control regulation systematically generates more social costs
than benefits, but also that those costs are most likely to fall disproportionately
on persons with lower incomes.  The political majority, after all, would favor a
regulatory standard set around point OR (for “over-regulation”) in Figure 1, at
which point they would run fewer risks and save more search costs than at the
optimal point o.  Moreover, consumers/voters with preferences to the right of
point OR are the most aware, influential, and politically active members of the
population, well-represented in the media and in policy-making circles.  In
addition, their interests in regulation guaranteeing higher quality would be
congruent with the interests of many powerful industry groups, for whom high
standards can eliminate low-cost competition and increase demand.97  Although
other interest groups may sometimes provide countervailing political pressure
against high regulatory standards, informal coalitions of upper-middle-class
95. Regulation is usually strictest in such cases because these are the areas in which the majority is
most concerned with saving search costs and avoiding costly mistakes.  See infra note 97.  To be sure,
the concerns of consumers/voters that trigger regulatory responses by government are rarely expressed
in terms of search costs or self-protection.  Nevertheless, they are manifest in the snap judgments virtu-
ally everyone draws—in health care above all—about the desirability of high mandatory standards.
96. See, e.g., Sidney L. Carroll & Robert J. Gaston, Occupational Restrictions and the Quality of
Service Received, 47 SO. ECON. J. 959, 965 (1981) (setting minimum standards for licensing electricians
found to increase accidental electrocutions; some citizens apparently elected to do their own electrical
work, with tragic consequences).
97. Although professional influence is usually blamed for excesses in occupational licensing,
economist Kenneth Arrow astutely observed as follows in a classic 1963 article on medical economics:
The general uncertainty about the prospects of medical treatment is socially handled by rigid
entry [i.e., physician licensing] requirements.  These are designed to reduce the uncertainty in
the mind of the consumer as to the quality of product insofar as this is possible.  I think this
explanation, which is perhaps the naive one, is much more tenable than any idea of a [medical]
monopoly seeking to increase incomes.  No doubt restriction on entry is desirable from the
point of view of the existing physicians, but the public pressure needed to achieve the restric
tion must come from deeper causes.
Arrow, supra note 81, at 966 (footnote omitted).  In a recent symposium revisiting the Arrow article,
not one of twenty-four separate comments focused on this perceptive explanation for the pervasiveness
of prescriptive regulation in the health care sector.  Symposium, Kenneth Arrow and the Changing Eco-
nomics of Health Care, 26 J. HEALTH POL. POL’Y & L. 823 (2001).
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voters and other special interests pressing for such standards will usually
prevail.
Figure 1 also demonstrates why over-regulation is an especially (perhaps
uniquely) severe problem in the health care sector.  Occupational licensure
excluding competent low-cost providers of health services from the market is
just one example of the political system’s insistence on high standards that
protect the political majority against seemingly deficient quality while
burdening lower-income consumers.98  The legal system’s enforcement of high
professional standards is another policy apparently supported by the political
majority that excludes low-cost options from the market and forces many lower-
income persons either to pay for increments of quality or legal rights they may
not want, or to go without health coverage altogether.99  In similar fashion, the
recent political backlash against managed care shows how the upper-middle-
class majority can obtain regulatory protection against what they perceive,
accurately or not, to be poor-quality health coverage provided by managed care
organizations.  In this case, the affluent majority with preferences to the right of
point OR seek not merely to reduce the risk that they might unwittingly
purchase low-quality health coverage, but also to limit what their employers can
buy on their behalf.  In all these matters, the political majority is strongly
supported by the medical profession and other supply-side interests, as well as
by sympathetic observers in the media and in the academy.
The political bias in favor of over-regulation is perhaps greater in the health
care sector than elsewhere in the economy for at least three reasons.  First,
health care has particular salience in politics because of its symbolic value in
establishing a politician’s empathy with constituents’ concerns.  Second, the
income-inelasticity of health care—that is, the tendency of people with higher
98. Carroll & Gaston, supra note 96.  State legislation also frequently requires health insurers to
provide specific types of coverage.  See, e.g., American Med. Sec., Inc. v. Bartlett, 111 F.3d 358, 362 (4th
Cir. 1997) (“The State of Maryland regulates health insurance, requiring that health insurance policies
afford at least 28 specified benefits.”).  Although these mandates are frequently attributed to lobbying
by the providers of the covered services, most of them would also appeal especially to upper-middle-
class consumers.  See generally Gail A. Jensen, Regulating the Content of Health Plans, in AMERICAN
HEALTH POLICY, supra note 45, at 167.
99. See supra notes 62-69 and accompanying text; see also Kenneth Arrow’s famous 1963 article,
which included the following observation:
[I]t would usually happen in a competitive market that many qualities will be offered on the
market, at suitably varying prices, to appeal to different tastes and incomes.  Both the licensing
laws and the standards of medical-school training have limited the possibilities of alternative
qualities of medical care.
Arrow, supra note 81, at 953.  Although Arrow failed to appreciate how conservative tendencies in
American law also contributed to the absence of product differentiation he observed, he rightly noted
the force of regulatory controls and professional standards in denying people opportunities to choose a
style of medical care appropriate to their circumstances.  Writing well before the Medicare and Medi-
caid programs and tax subsidies for employer-purchased coverage poured enormous new public and
private resources into health care and engulfed the industry in new waves of moral hazard, Arrow had
little occasion for concern about the misallocation of resources that might result if society’s usual
mechanisms for making vital trade-offs are disabled.  See supra text accompanying notes 85-90.
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incomes to spend higher percentages of their incomes on health services100—
widens the usual preference gap between the upper-middle class and the rest of
the population—that is, the distribution represented by the bell curve in Figure
1.  Finally, both the likelihood and the regressivity of over-regulation are
increased by the tendency of most consumers/voters to believe that insurers or
their employers (rather than themselves) will pay the added costs of whatever
quality, legal rights, or coverage they would like regulation to guarantee.101
When all these factors are combined, it seems certain that the political
majority, in league with professional and other interests in the health care
industry, will demand not just over-regulation of the health care sector (that is,
a regulatory line drawn at point OR in Figure 1), but hyper-regulation (for
example, a line drawn somewhere in the vicinity of point HR).102  The irony is
that majoritarian politics, combined with the public’s general unawareness of
health care costs, allows the elite classes, including many self-proclaimed
consumer representatives as well as organized professional groups, to design
and maintain a system that meets their own particular needs but leaves less
privileged citizens who are not qualified for publicly financed care with a
Hobson’s choice: either coverage for “Cadillac” care or no health coverage at
all.  Ruled as it is by and for dominant elites, the U.S. health care system
imposes large, unfair, and unnecessary economic burdens on ordinary working
people.
C. Regressivity Compounded
The impositions by the haves on the have-nots (or, more accurately, the
have-lesses) do not necessarily stop with maintaining high regulatory and legal
standards to protect affluent consumers against the risk that they will receive
health care or health coverage they consider inferior.  Even though all
participants in a given health plan pay equivalent premiums and have the same
nominal entitlements, individuals who are more demanding, knowledgeable,
100. PAUL J. FELDSTEIN, HEALTH CARE ECONOMICS 86-87 (5th ed. 1999).
101. Still another reason why upper-middle-class consumers might prefer standardization of health
care and health coverage is that product differentiation interferes with price competition by adding
dimensions to the product that make price shopping more difficult.  Hammer & Sage, supra note 15, at
275 nn.119-20.  Thus, if health plans were not generally close substitutes for each other, an employer
would find it harder to bargain over price with the plan it most desired.  Likewise, consumers would
have to pay more for access to higher-quality providers in a system featuring differentiated products,
since plans striving for qualitative superiority would have to reward superior providers.  (Currently,
sophisticated consumers have an advantage in identifying and patronizing the best providers in their
communities and can obtain their services at little or no additional cost to themselves.)  See infra note
103.
102. Note that many of consumers’ concerns about incurring excessive search costs and purchasing
in ignorance could be addressed by public or private certification or accrediting programs that distin-
guish high-quality providers or plans from those of lesser quality but do not exclude the latter from the
market.  Upper-middle-class consumers would still prefer regulatory standardization of health care and
health coverage, however, to preclude their employers from making choices with which they might dis-
agree.  Thus, they have an additional reason to want the government to foster health plans in which less
sophisticated consumers also enroll, paying equivalent premiums without the same assurance of
equivalent value.
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articulate, or assertive may regularly receive more or better services than other
patients.103  For example, physicians and other decision-makers may perceive
that certain patients have especially high expectations concerning their health
care, and may strive to accommodate those expectations while economizing on
the care of others.  On the other hand, some patients may be able to make more
persuasive demands on their physicians because they are adept at using the
Internet or are otherwise more knowledgeable about their health problems and
treatment options.  Others may simply be more skillful or persistent in
questioning their doctors or seeking second opinions or may signal a litigious
nature that providers or the plan might hope to appease by providing extra
services.  On top of all this, higher-income patients will also enjoy a
disproportionate share of plan resources to whatever extent they are less
deterred from consuming services by cost-sharing requirements.104  It seems
inevitable that patients in higher socioeconomic classes will derive significantly
greater value from their health plans than less affluent enrollees paying
identical premiums.105  The regressive cross-subsidies implicit in American
health care will therefore exceed even those inherent in its hyper-regulation.
To be sure, the inequities detailed above are ameliorated to the extent that
employers structure their health benefits in ways that cause employees to
segregate themselves in different health plans on the basis of risk aversion and
ability to pay.  As noted earlier, some employers now offer their employees
103. “Well-off and influential patients tend to link up with elite academic and private physicians, to
sustain their relationships with these physicians, and to benefit from these physicians’ sponsorship and
advocacy in hospital and other institutional settings.  Middle-class patients tend to access a lower level
of sponsorship and advocacy . . . .”  M. Gregg Bloche, Race and Discretion in American Medicine, 1
YALE J. HEALTH POL’Y L. & ETHICS 95, 108 (2001) (citing RAYMOND S. DUFF & AUGUST B.
HOLLINSHED, SICKNESS AND SOCIETY (1968)).
104. Both theory and intuition suggest that cost sharing would have significantly greater effects on
consumption of insured services by lower-income persons, thus adding to the regressiveness of insur-
ance plans that ostensibly provide equal benefits for all enrollees.  For empirical evidence, see JOSEPH
NEWHOUSE ET AL., FREE FOR ALL: LESSONS FROM THE RAND HEALTH INSURANCE EXPERIMENT
339 (1993) (“Ambulatory services were more responsive to cost-sharing for the poor than for the well-
to-do; the opposite was true for hospital services.”).  Although the RAND study found that, overall,
“the percentage reduction in expenditure [attributable to cost sharing] did not differ strikingly by
income group,” id., a lower cap on out-of-pocket payments for the poor complicated the analysis,
probably explaining the absence of deterrence with respect to inpatient care.  See id. at 46-47.  Most
significantly for the purpose of identifying regressivity in employee health plans, the RAND data
showed (despite the assertion that the overall effects of cost sharing did not differ by income group)
that cost sharing had noticeably greater effects on middle-income persons than on either the higher-
income group or the poor.  Id. at 46 (table).
105. This point was driven home for me when, in the 1970s, my own employer merged its health
plan for hourly-paid workers with its similar plan for faculty and staff.  The result of this seemingly pro-
gressive move was in fact regressive, as the faculty’s premiums fell significantly while the workers’ pre-
miums rose.  If this phenomenon is pervasive (as I suggest it is), the U.S. health care system raises ques-
tions of social justice quite different from the ones usually asked.  For suggestive evidence on nonracial
socioeconomic disparities in health plans, see NEWHOUSE ET AL., supra note 104, at 46 (table) showing
significantly higher predicted levels of use of medical services by higher-income persons than by
middle-income persons); HMO Enrollees Experience Fewer Disparities than Other Insured Populations,
5 HEALTH CARE FIN. & ORG. no. 2 (April 2002) (Findings Brief) (reporting unpublished findings by
Kevin Fiscella et al. that HMOs reduce disparities based on education level but not income).
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multiple health plans with different prices so that their employee populations
are somewhat stratified, with higher-income persons subscribing to costlier
plans.  Nevertheless, the overall regressivity of American health care seems
clear.  Not only is the fixed-contribution method of financing employee
coverage still very far from being the norm, but (as earlier observed) the
structure of tax subsidies makes it likely that any floor an employer sets—
including its contribution for a basic point-of-service plan—will be a relatively
high one.  In addition, hyper-regulation makes any qualitative differences
between health plans relatively narrow ones.  Because the entitlements on offer
in the market for health coverage are all so similar at the core, consumers are
unlikely to sort themselves out so that those who demand more and better
services consistently pay the full incremental cost of the additional attention, or
higher-quality services, they receive.  Indeed, employees who are confident they
can make any system work to their advantage may see no need to opt for a
costlier plan.
Without objective evidence of consumers’ true preferences with clear and
accurate information, it would be impossible to estimate the magnitude of
regressivity in a single large employment group, let alone to measure it in all
privately financed health care.  Either for this reason, or simply because
analysts do not recognize the existence of inequity of the kind hypothesized
here, no one appears to have measured the extent of the system’s impositions
on lower-income premium payers.  On the other hand, many analysts have
found racial disparities in the health care system.106  Although these disparities
are generally attributed to racial bias, they may also be artifacts of patients’
varying ability to “work the system,” and of providers’ discretion to prescribe
services in accordance with their perceptions of patients’ expectations rather
than strictly according to objective medical need.107  Racial bias and stereotyping
obviously merit study, but only political correctness (including a disinclination
to recognize hypocrisy in the current regime) can fully account for the research
community’s focusing of so much attention on racial issues while neglecting the
fundamental unfairnesses noted in this discussion—the burdens of which fall
most heavily, ironically, on some of the very groups for whom solicitude is most
fervently expressed.  Similarly, experts widely study and deplore the inequity
represented by the huge number of Americans without health insurance, while
106. For overviews of the findings on racial disparity, see INSTITUTE OF MEDICINE, UNEQUAL
TREATMENT: CONFRONTING RACIAL AND ETHNIC DISPARITIES IN HEALTH CARE (2002), available
at http://www.nap.edu/books/030908365x/html/ (last visited Sep. 6, 2002); Bloche, supra note 103.
107. Some analysts have recognized that racial disparities may be ascribed in part to such factors.
See, e.g., Robert A. Lowe et al., Effect of Ethnicity on Denial of Authorization for Emergency Depart-
ment Care by Managed Care Gatekeepers, 8 ACAD. EMERGENCY MED. 259 (2001) (observing correla-
tion between race and discrepancies in treatment authorization but suggesting as a possible explanation
that black and Medicaid enrollees were less effective advocates for their own care); Stuart E. Sheifer et
al., Race and Sex Differences in the Management of Coronary Artery Disease, 139 AM. HEART J. 848
(2000) (race-related disparities attributed to socioeconomic differences and black patients’ resistance to
cardiac procedures, as well as to racial bias).
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rarely attributing it to hyper-regulation maintained in the interest of dominant
elites.
The most influential observers of the American health care system—
including public officials, media commentators, academics, and denizens of
wealthy foundations and other nongovernmental organizations—would
probably argue that health care consumers do in fact have adequate chances to
economize but have chosen not to do so.  To these observers, health care of
acceptable quality is inevitably expensive—it costs what it costs—and no one
could rationally want anything less.  The principal policy question, in their
minds, is how to assist more people in paying for the high-quality care
mandated by current regulatory requirements and to ensure its equitable
distribution by anti-discrimination rules.  An individual’s personal support for
progressive policies for the long run, however, does not justify supporting
policies that are powerfully regressive in the short run, especially when, as
Keynes said, “in the long run we are all dead.”108  There is, after all, ample
reason to doubt that the political system will ever finance a system guaranteeing
everyone care that meets the high standards these advocates support.109  Indeed,
where other nations have more or less arranged their health care systems so
that those who want more or better care than is suitable for the median citizen
must pay more for it, the United States has structured things so that lower- and
middle-income premium payers bear heavy burdens so that the elite classes can
continue to enjoy the style of health care to which they are accustomed.
Few observers are troubled by the absence of explicit economizing
opportunities in the health care marketplace.  Indeed, far from deploring the
lack of overt qualitative differences between health plans, most observers resist
the suggestion that ordinary people should be free to make even fair bets
against their developing a desire for especially expensive health services of
uncertain efficacy.  Although some experts argue that people want to be
protected against making bets of this kind,110 what they may really be saying is
that they themselves and people like them would prefer not to witness bets
turning out badly for needy bettors.111  But assuaging guilt about life’s unfairness
108. JOHN MAYNARD KEYNES, A TRACT ON MONETARY REFORM 80 (1923).
109. Because the cost of meeting high standards rises over time much faster than GDP increases, the
political difficulty of providing universal access to care that meets such standards increases every year it
is not done.  The failure of the Clinton administration’s health reforms may have been attributable to
the high cost of trying to guarantee costly mainstream health care to everyone.  See HAVIGHURST,
HEALTH CARE CHOICES, supra note 3, at 79 (“[T]he political problems that the Clinton program
encountered were traceable in large measure to its egalitarian thrust.”).
110. See, e.g., Bruce C. Vladeck, The Market v. Regulation: The Case for Regulation, 59 MILBANK Q.
209, 211 (1981).  According to Vladeck, “Consumers have sought the kind of health insurance they
have . . . precisely because they don’t wish to be forced to make rational trade-offs when they are con-
fronted with medical care consumption decisions.”  Although it is true that people buy coverage to
avoid difficult choices, Vladeck’s statement begs the question whether people have in fact been offered
choices requiring them to face the high marginal cost of the additional protection he says they demand.
111. To be sure, as Vladeck says, “As a society, we may be prepared to pay a substantial economic
premium to insulate people from having to make such decisions.”  Id. at 212.  But “society” has not in
fact chosen to pay a “substantial economic premium” through a fair system of taxation and subsidies so
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cannot justify imposing heavy costs on those who would prefer to spend their
moderate incomes on things other than generous health insurance.  Indeed, an
efficiency claim based on Kaldor-Hicks principles112 would seem to fail an
elementary morality test if the majority that is offended when other people
make economizing choices is demonstrably unwilling to provide public
financing of the care they do not wish others to deny themselves.113  In any
event, apparent egalitarianism and a commitment to high standards create a
very convenient facade for hiding the regressive cross-subsidies that currently
help to finance the United States’ bloated health care system.
D. Hyper-regulation: The New Wave
Recent legislative and regulatory moves against managed care plans take on
new significance in the context sketched in the foregoing discussion.  Indeed,
most of the latest actions and proposals may easily be seen as new reflections of
the political dominance of upper-middle-class consumers desiring to see their
employers prevented from choosing a health plan they might regard as inferior,
and also desiring to see their health plans limited in their ability to resist the
demands of patients with especially high expectations.  Even modest “fixes” of
minor problems perceived to exist in today’s managed care plans need to be
scrutinized to see if they further reduce plans’ flexibility in addressing legitimate
cost and quality problems or add to their administrative costs.  Given the
margin at which managed care regulation already operates (presumably
represented by a line at, if not well to the right of, point OR in Fig. 1), new
regulatory restrictions on health plans are almost certainly poor substitutes for
fundamental reforms—aimed, for example, at restoring some freedom of
contract and making plans legally accountable when care provided under their
auspices fails to meet contractual standards.114  Unfortunately, today’s
regulatory agenda appears to presume that the market reform strategy—of
letting appropriately subsidized consumers and their agents make informed
choices among freely competing health plans featuring different trade-offs
between cost, quality, and financial protection—has failed a fair market test115
and that more, not less, standardization is called for.  Consumer-voters, well
that ordinary people can afford generous health coverage.  Instead, it maintains a system that forces
lower- and middle-income consumers to pay “substantial economic premium[s]” to health plans so that
upper-middle-class consumers can be spared both the making of difficult choices themselves and the
spectacle of lower-income individuals making them.
112. See supra note 94.
113. Conceivably, someone might claim that limited tax and other subsidies are provided specifically
to compensate for marginal impositions on lower-income premium payers.  However, that argument
simply makes the system seem even more obviously rigged to accommodate concerns of the affluent
minority, rather than designed to help people buy a merit good they truly need.
114. On the desirability of making plans presumptively vicariously liable for providers’ torts (as a
way of finally aligning plan and physician interests, inducing integration, increasing plans’ stake in the
quality of care, and generally legitimizing managed care itself), see supra notes 42-43 and accompany-
ing text.
115. See Havighurst, supra note 1, at 1-14.
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insulated from cost concerns, have proved fertile ground for horror stories in
the media and for politicians taking the populist line urged by medical interests.
A particularly vexing item on the agenda for reforming managed health care
would increase the exposure of health plans to lawsuits for personal injuries
when they arguably fail to live up to their obligations to cover to particular
services.116  A powerful case can be made for giving consumers adequate legal
redress against health plans that breach their contracts.  On the other hand,
legal rights can easily be abused—especially if, as appears to be the case, courts
and juries are prejudiced against health plans, quick to exercise hindsight in
difficult cases, and skeptical of contracts significantly limiting patient rights.117  If
plans are fearful of unwarranted liability or even of the costs of defending
defensible cases, they are likely to display unwarranted generosity, particularly
toward anyone deemed likely to make legal trouble.  Perhaps the most
promising strategy would be to restore plan liability while explicitly authorizing
plans to negotiate contractual limits on their legal exposure118 and to renegotiate
their contracts to clarify that their obligations do not include underwriting
everything professional standards might indicate.119
Another prominent element of the reform agenda is a movement to install
so-called external review as the sole method for finally resolving close coverage
issues.  Under external review, health plans’ own interpretations of their legal
obligations to cover particular services would be only preliminary to appeals to
professional experts lacking any connection to the plan and any commitment to
carrying out its priorities in spending limited resources.  Even if the external
reviewer was charged with interpreting the plan’s contract rather than with
applying a purely professional standard, interpretations could easily differ in
similar cases.  Even more seriously, although much would depend on how the
116. See generally Wendy K. Mariner, Slouching Toward Managed Care Liability: Reflections on
Doctrinal Boundaries, Paradigm Shifts, and Incremental Reform, 29 J.L., MED. & ETHICS 253 (2001).
The need for legislation results from ERISA.  See supra note 72-74 and accompanying text.
117. On the environment health plans face when hauled before the courts, see Bob Van Voris, Poll-
sters Find No Love for HMOs, NAT’L L.J., Feb. 11, 2002, at 1 (fifty-three percent of respondents said
that, as jurors, they would be “likely to vote for” a plaintiff against an HMO or hospital, while only
eight percent would tend the other way).  On the tendency of courts to disregard or liberally construe
contractual limits on health coverage, see supra text accompanying notes 62-67.
118. It would be desirable, for example, to preserve the principle announced in Firestone Tire and
Rubber Co. v. Bruch, 489 U.S. 101, 110-15 (1989), in which the Court held that, under ERISA, employ-
ers could confer substantial discretion on plan administrators interpreting coverage provisions of the
plan, whose decisions would then be subject to review only for arbitrariness.  Unfortunately, pending
federal legislation looks in exactly the opposite direction.  See, e.g., Bipartisan Patient Protection Act,
S. 1052, H.R. 2563, § 104, 107th Cong., 1st Sess. (2001) (passed June 29 and Aug. 2, respectively)
[hereinafter Bipartisan Patient Protection Act] (proposed new § 503C(d)(3)(E) of ERISA would direct
external reviewers to “consider the claim under review without deference to” the plan’s decision and to
“consider, but not be bound by,” contractual provisions); see also Havinghurst, supra note 1 at 3 n.12
(describing how the legislation, although passed in 2001, is still waiting action by a joint conference
committee).
119. The bargaining power of employers and any opportunity for consumers to choose between
plans offering different legal rights should be sufficient to avoid the charge that contractual limits are a
contract of adhesion.  Cf. Madden v. Kaiser Found. Hosps., 552 P.2d 1178 (Cal. 1976) (holding that
arbitration clause negotiated by employer was enforceable).
HAVIGHURST_FMT.DOC 10/23/02  1:50 PM
92 LAW AND CONTEMPORARY PROBLEMS [Vol. 65: No. 4
requirement for external review was written and implemented, it could easily
amount to a powerful reassertion of the professional paradigm, making
professional standards even more binding on health plans than they currently
are.120  Unfortunately, fear of new legal liability has apparently led the managed
care industry to accept external review as a less objectionable alternative.
Under external review, however, private health plans would lose control over
coverage determinations and, with it, much of their raison d’être.121
Requiring external review of health plans’ coverage decisions would rig the
system still further in favor of the privileged minority of upper-middle-class
consumers.  An excellent illustration of this tendency is provided by the facts in
a prominent ERISA case recently decided by the Supreme Court.  In Rush
Prudential HMO, Inc. v. Moran,122 the plaintiff, a resident of Illinois, sought
treatment from the defendant HMO for a severe neurological problem in her
shoulder.  When the conventional therapies provided by her HMO doctors did
not relieve her symptoms, she located an out-of-network surgeon in Virginia
specializing in a unique kind of micro-reconstructive surgery, traveled to
Virginia for examination, and became a candidate for the complicated
operation.  Although her HMO physician was willing to recommend this
surgery, the plan’s consultants (including several outside experts) did not
approve it.  Ms. Moran then underwent surgery in Virginia anyway, paid the
cost ($94,841.27) herself, and sued the HMO to recover that amount.  After
lengthy appeals and negotiations, she eventually persuaded a court to order
external review of her case by an independent physician pursuant to an Illinois
statute.  The reviewer, differing with the earlier experts, agreed that the more
radical surgery, although not exactly what he would have recommended, was
“medically necessary.”  The court of appeals eventually decided that the Illinois
law was not preempted by ERISA and ordered the HMO to pay.123  Its ruling on
the scope of ERISA preemption was affirmed by the Supreme Court.124
Putting aside the important legal question resolved in Moran,125 it is helpful
for present purposes to consider the outcome achieved in the case under the
120. See, e.g., Bipartisan Patient Protection Act, supra note 118.
121. See generally Havighurst, supra note 45.
122. 122 S. Ct. 2151 (2002).
123. Prudential HMO Inc. v. Moran, 230 F. 3d 959 (7th Cir. 2000).
124. For other examples of the recent willingness of courts to reinterpret ERISA in ways that give
wider effect to state law and state regulatory reforms, see Ky. Ass’n of Health Plans, Inc. v. Nichols, 227
F.3d 352 (6th Cir. 2000) (holding state “Any Willing Provider” law not preempted); Lazorko v. Pa.
Hosp., 237 F.3d 242 (3d Cir.) (holding claim for injuries not preempted where managed care organiza-
tion’s refusal to rehospitalize patient could be treated as medical, not coverage, decision) cert. granted,
122 S. Ct. 2657 (2002); Pappas v. Asbel, 768 A.2d 1089 (Pa. 2001) (upholding personal-injury claim
against HMO for alleged delay in treatment).
125. The Court held, 5-4, that ERISA’s saving clause, see note 74 supra, allowed Illinois to impose
the binding external review requirement on the HMO, despite Congress’s intention to create a uniform
federal regime governing employee benefit plans.  The state law was deemed to pass several tests for
establishing that a state law “regulates insurance” and is therefore saved from preemption by the saving
clause. Madden, 122 S. Ct. at 2158-64.  More controversially, the Court held that Illinois’s requirement
for binding external review did not amount to an impermissible alternative to ERISA’s exclusive
HAVIGHURST_FMT.DOC 10/23/02  1:50 PM
Page 55: Autumn 2002] HOW THE REVOLUTION FELL SHORT 93
Illinois requirement for external review.  Most people would probably applaud
the result as a patient victory over a managed care plan interested only in its
own bottom line.  Indeed, it is easy to admire Ms. Moran’s aggressiveness in
seeking the best available treatment (perhaps finding the Virginia surgeon
through a creative web search126) and her persistence in pursuing her legal rights.
On reflection, however, it should be obvious that such aggressiveness and
persistence should not necessarily be rewarded by making her HMO pay for the
care she obtained.  After all, other members of the HMO could not realistically
have expected to get similar treatment for the same condition, yet they paid the
same premiums she did.  Indeed, the HMO seems to have performed a valuable
service to its subscribers in conscientiously administering the pool of insurance
premiums to ensure that one patient displaying special initiative would not get
more out of the plan than other subscribers could reasonably expect to get
under similar circumstances.127  The irony is that most observers of this case,
both casual and expert, are likely to be persons with high expectations with
respect to their own health care and thus to see the HMO’s action as precisely
what they expect regulation to prevent and Ms. Moran’s presumed rights as
precisely what they expect the law to vindicate.128
The Moran case and the Illinois regulatory regime it brought to bear on the
defendant HMO illustrate how the political/legal system, with its essentially
populist view of health care choices, tends to regulate the financing and delivery
of health care to meet the expectations of upper-middle-class elites.  External
review essentially denies health plans any intermediary role in selecting
treatments, limiting them to a passive role similar to that played by pre-
revolutionary health insurers, which dutifully paid for any care meeting
professional standards as determined by professional authorities.  Not only does
such regulation drastically curtail opportunities for health plans to differentiate
themselves, but a given plan could no longer hope to achieve consistency in
administering its benefits.129  Moran also illustrates how professional judgments
of outside reviewers are apt to vary widely in difficult cases.  In addition, the
Illinois scheme required the plan to submit to external review only when the
regime for enforcing civil obligations of employee benefit plans.  Id. at 2164-71.  In dissent, Justice
Thomas argued that the Illinois statute did create remedies inconsistent with ERISA’s exclusive
enforcement mechanisms and persuasively objected to the majority’s view that the Illinois-mandated
review resembled a “second opinion” requirement more than a requirement for binding arbitration.  Id.
at 2171-78.  For the majority, it was enough that an action to enforce the external reviewer’s decision
would still lie in federal court under ERISA’s civil enforcement provisions, 29 U.S.C. § 1132(a) (2002).
126. The Virginia surgeon’s website can be visited at http://jkterzis.com (last modified Sep. 17,
1998).
127. The district court in Moran had carefully reviewed the plan’s handling of the claim, finding no
abuse of discretion.  See Prudential HMO v. Moran, No. 98-C-442, 1999 WL 417384 (N.D. Ill. June 15,
1999).  The impression given by this review is that the plan went to great (and costly) lengths to make
sure that its decision was right.
128. See, e.g., Ellen Goodman, A Case for Better Treatment, RALEIGH NEWS & OBSERVER, Jan. 22,
2002, at 9A (syndicated columnist characterizes Moran case as “a timely, chilling reminder that patients
haven’t yet won protection from budgets and [HMO] bureaucrats”).
129. See supra note 118.
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judgment of the patient’s HMO doctor differed from that of the HMO’s
medical director and consultants.  Obviously, not all primary care physicians
would be equally knowledgeable about exotic alternatives such as the one Ms.
Moran brought to her doctor’s attention.  Nor would they be equally willing to
stand up to the plan for a particular patient, given the possible adverse
consequences of doing so.130  In other cases, it would be up to the patient to
initiate the challenge, which might not occur if the doctor had been co-opted
sufficiently to withhold information about desirable alternatives or if the patient
was temperamentally not inclined to fight.
In any event, the model of health care decision-making that is increasingly
taking hold in the public mind and in regulatory policy is one that marginalizes
the health plan as a responsible player.  This model serves physicians and the
provider community well, while also protecting those consumers/voters who
especially want health care to be available to them without constraints.  The
political process has proved a powerful tool enabling special interests to shape
the system to their liking.  The costs of the system, borne in large measure by
the mass of Americans who cannot easily afford such luxury, remain—by
apparent design—hidden well enough that the day of reckoning is at least
delayed.
VII
MANAGED CARE IS DEAD!  LONG LIVE MANAGED CARE!
Despite the apparent success of the counter-revolution against managed
health care, it is hard to predict a long reign for a restored regime founded on
such professional values as the “any-benefit” standard for medical and coverage
decisions and the illegitimacy of intermediaries acting as consumer agents in
procuring medical services.  Indeed, rising health care costs are already a severe
problem in the wake of the counter-revolution, leading to speculation that
political conditions are ripening for a “perfect storm” that will drive health
policy and the health care industry into uncharted waters.  Although it would be
foolish to predict where things will end up, this article concludes by exploring
the possibility that managed care or something like it, perhaps bearing a less
technocratic name, will re-emerge to restart and evenutally complete the
American health care revolution, finally giving consumers some strategic
control over their aggregate spending on health services.  Without observing all
the possibilities or all the political, legal, and practical pitfalls that lie in each
130. Note that the Illinois law irrevocably set up each treating doctor as an adversary of the patient’s
health plan, allowed to appeal over its head to professional authority.  The same adversarial model of
plan/provider relations, obviously destructive of any effort to integrate physicians and health care
financing, see supra notes 5-7, 36-44 and accompanying text, is also embodied in the new legal right
physicians increasingly enjoy to participate in plans that do not wish to retain them.  See supra note 18
and accompanying text.  These legal developments are among the most dramatic evidence of the
remarkable success of the medical profession’s counter-revolutionary move to reassert the professional
paradigm of medical care, to remove economic trade-offs from consideration in clinical practice, and
generally to roll back market reforms aimed at empowering consumers and their agents.
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possible path, the following paragraphs suggest what health plans might do,
individually and collectively, to establish themselves as legitimate, trustworthy
executors of consumer preferences.  Specifically, I suggest that health plans
might finally begin to differentiate themselves in ways that enable them to serve
the economic interests, as well as the health care needs, of different subsets of
the consuming public.  Only a responsive market offering consumers real
choices can ameliorate the regressivity and misallocative tendencies that this
article has observed in American health care.
The discussion here focuses only on what private actors, not
government, might now do to revive the lost revolutionary cause.  It is
necessary to hope, of course, that the political/legal system, which is
congenitally uncomfortable with any arrangement that contemplates denying a
desired health service to anyone except on the ground of its sheer
worthlessness, will not finally foreclose all remaining opportunities for private
innovation addressing the dilemma of health care costs.131  But, with health care
costs spiraling out of control, government might at least look the other way as
employers and health plans begin to explore new ways to harness consumer
cost-consciousness as a counterweight to the system’s propensity to overspend.
For their part, employers are already shifting greater shares of the cost burden
directly to employees and contemplating reliance on fixing their contributions,
rather than redesigning their benefits, to control their costs.  Although some
recent moves by employers and health plans seem shortsighted,132 competitive
pressures and intensifying cost concerns may yet induce health plans to think
outside the box, beyond the professional paradigm and individual cost sharing.
Fortunately for the scenario-cum-agenda sketched here, regulation and
the legal system do not appear to pose insurmountable obstacles to offering
consumers an appreciable range of health care choices.  Indeed, most of the
failings of the managed care movement are attributable less to substantive law
and regulation than to health plans’ own conservatism and the nature of their
contracts with subscribers.  Thus, the “medical necessity” criterion appears in
virtually all contracts for health coverage, not because that criterion was
generally mandated by law, but because health plans voluntarily embraced a
powerful industry convention.  In the Moran case, the Supreme Court observed
131. On the potential destructiveness of federal patient protection legislation pending in 2002, see
note 133 infra; see also Havighurst, supra note 1, at 4 n.12 (speculating that the federal bill is unlikely to
leave the joint conference committee).
132. One new development is increasingly complex and burdensome cost-sharing arrangements
(some featuring different co-payments for as many as three tiers of provider or product choices).
Another significant trend among employers is to make so-called “defined contributions” to individual
accounts that employees can use to purchase health care directly, with protection against very large
expenses supplied by catastrophic coverage.  These various arrangements either obviate activist roles
for managed care plans or bypass such plans altogether, strongly implying that they are no longer
capable of adding significant value.  Thus, the new strategies presume that individual consumers are
good enough decision makers with respect to health care not to need assistance from intermediaries of
any kind.  For convincing reasons why such arrangements are unlikely to slow cost trends attributable
to uncontrolled moral hazard, see Victor Fuchs, What’s Ahead for Health Insurance in the United
States?, 346 NEW ENG. J. MED. 1822 (2002) (also regretting on social grounds the higher burdens the
new arrangements inevitably impose on older or sicker insureds).
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that the HMO defendant “chose[] to guarantee medically necessary services to
plan participants” and that “insurance contracts do not have to contain such
guarantees, and not all do.”133  Moreover, the Illinois external review
requirement at issue in Moran applied only to disputes over medical necessity,
apparently leaving other coverage limits to be administered by plan personnel,
subject to ordinary judicial review in suits for breach of contract.  The situation
in Illinois following Moran thus invites health plans to specify criteria for
coverage that do not incorporate professional standards as such, and there
appears to be similar room in other states for defining coverage in
unconventional terms.134  Health plans may therefore have an opportunity to
break their attachment to medical necessity and professional standards—
inefficient criteria in any event—and to develop various new ways of stating
their obligations to subscribers.  Although the legal system has been
unreceptive to contractual limits on coverage in the past, a new crisis in health
care spending might induce courts, legislatures, and regulators finally to respect
well-crafted efforts to respond to consumer cost concerns.  Also, while fear of
adverse selection has heretofore inhibited substantial qualitative differentiation
among health plans, contractual limitations can do much to prevent those
initially choosing cheaper coverage from upgrading when a medical need
appears.135
To be sure, any general criterion for coverage other than medical
necessity would be subject to the charge of vagueness and ambiguity and
difficult to apply in practice.  These difficulties could be largely overcome,
however, if the managed care industry undertook collectively to specify
standard contract language defining three or four “tiers” of coverage,
representing graduated levels of generosity, and gave consumers other guidance
concerning the relative generosity of various plans.136  If consumers were better
133. 122 S. Ct. at 2167 n.10.
134. Even if other states seem to mandate medical necessity as a standard in all health plan
contracts or to require external review of all coverage decisions (not just those based on medical
necessity), there may be substantial room for escaping professional standards by contract.  Thus, a
contract may adopt the medical necessity criterion but define it in a way that makes the actual test a
contractual rather than a professional one.  Likewise, a contract might expressly bind external
reviewers to apply standards drawn from the contract, not from professional sources.  But see
Bipartisan Patient Protection Act, supra note 117 (proposed new § 503C(d)(2) of ERISA would
mandate external review of any coverage decision based on “medical necessity or appropriateness” or
otherwise “based on grounds that require an evaluation of the medical facts by a health care
professional”; proposed new §§ 503C(d)(3)(B), (C) would free reviewers from honoring contractual
limits unless the applicable exclusion is categorically or numerically “exact”).  Cf. HAVIGHURST,
HEALTH CARE CHOICES, supra note 3, at 139-43 (observing the inefficiency, due to inevitable
arbitrariness, of “exact” categorical exclusions, fixed dollar or service limits, and cost-sharing
requirements).  Rather obviously, passage by Congress of the Bipartisan Patient Protection Act in its
current form would virtually eliminate contractual limits on coverage as reliable instruments by which
health plans might curb spending on cost/benefit grounds.
135. See supra note 53 and accompanying text.
136. A similar strategy for assisting consumers choosing complex insurance products has been
employed by the federal government with respect to so-called “Medigap” coverage.  42 U.S.C.A. §
1395ss (2000), 42 C.F.R. § 403.200 (2000) (differentiating ten different tiers or varieties of coverage
supplementing Medicare benefits).  For sample definitions, see HAVIGHURST, HEALTH CARE
HAVIGHURST_FMT.DOC 10/23/02  1:50 PM
Page 55: Autumn 2002] HOW THE REVOLUTION FELL SHORT 97
informed in this way, it should be possible to enforce their ex ante choices even
if regrets arose ex post.  Industry efforts to standardize coverage criteria would
also enhance consistency and predictability in contract administration, obviating
many disputes.  Under a new generation of contracts, physician reviewers would
serve only as technical experts in applying plan-specific criteria, not as arbiters
of treatment under professional standards.
Obviously, contract drafters would want to leave as few coverage issues
as possible to be resolved under an inevitably uncertain general standard, even
one that had acquired some conventional meaning.  To add desirable
concreteness to differentiated health care contracts, ethicist Haavi Morreim has
recently endorsed “guidelines-based contracting.”137  By incorporating selected
clinical practice guidelines and protocols by reference in their contracts with
subscribers, health plans could minimize arbitrariness and inconsistency of the
kind suspected in coverage determinations today.  Ideally, guideline producers
would expressly tailor their products to correspond to the different general
coverage criteria in use in the industry.  Again, industry collective action could
be helpful in clarifying and validating the options being offered.  Private (or
public) certification of alternative guidelines might also enhance public
confidence in plan policies.
A health plan might also improve its reputation for fairness if, in cases
where its contract did not cover a costly procedure, it was willing to indemnify
the patient in an amount equivalent to the cost of the usual treatment.138
Certainly, the equitable position of the HMO in the Moran case would have
been stronger if it had not conditioned its willingness to pay anything toward
Ms. Moran’s care on her acceptance of its standard therapy.  It is not known
how many of today’s health plans provide cash indemnities for patients who
elect treatments costlier than those the plan covers.  Most plans, however, seem
to approach coverage decisions on the premise that they are implementing
objective professional standards and are under no obligation to subsidize
deviations from them.  This pretense of omniscience in applying professional
standards is a major source of managed care’s public and provider relations
problems.  If it were dropped in favor of pure contractual standards, a plan
could convincingly claim that it was doing nothing more than administering a
limited pool of resources on contractual terms, thus averting criticism (and
possible legal liability) for “practicing medicine.”
Health plans could improve their contracts and their service to
subscribers in other ways as well.  A heroic but vital step would be acceptance,
CHOICES, supra note 3, at 192-94 (suggesting contract language defining six possible alternative criteria
for coverage, in ascending order of liberality).
137. HAAVI MORREIM, MAKING HEALTH CARE ACCOUNTABLE 126-36 (2000).  See also
HAVIGHURST, HEALTH CARE CHOICES, supra note 3, at 222-64 (elaborating the case for incorporating
selected guidelines in health care contracts, with examples); Havighurst, supra note 24, at 796-804
(observing potential of practice guidelines for overcoming contract failure in health care).
138. For other ways in which a health plan might clarify that it has not set itself up as the final
arbiter of treatment, see HAVIGHURST, HEALTH CARE CHOICES, supra note 3, at 140, 189 (suggesting
high—e.g., 50%— cost sharing for nonstandard care and/or plan loans to patients desiring such care).
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by contract or by statute, of substantial legal responsibility both for their own
errors in determining coverage and for the torts of their chosen providers.  If a
plan were to accept such liabilities by contract rather than having them imposed
by substantive law, it would be able to set terms, procedures, and limits striking
a proper balance between accountability and cost.  Regrettably, the managed
care industry has been so fearful of liability exposure that, rather than
defending its members’ freedom to innovate in the interest of consumers, it has
taken the opposite tack of seeking the cover of regulation and professional
standards for virtually everything its members do.  To be sure, the industry’s
reluctance to accept legal accountability is attributable in large measure to the
legal system’s inability to protect health plans from both unwarranted liability
and the high cost of defending unwarranted lawsuits.  But reasonable exposure
to liability is essential to deter firms from abusing their competitive freedom,
which must be preserved if they are to serve consumers well.  Indeed, if private
health plans gain protection from litigation by surrendering their freedom to
offer consumers meaningful alternatives, there is no obvious reason why they
should not be replaced by a government-run financing system.139  The managed
care industry’s reluctance to accept legal responsibility for its members’
performance is a major reason why the health care revolution failed140 and why
it may be impossible to restart it.  By the same token, nothing could do more
than legal accountability to help health plans regain the trust they need to
perform the sensitive tasks assigned to them in the health care revolution.
Note that there are two kinds of legal liability to which health plans
must be exposed on reasonable terms if their legitimacy as participants in health
care decisions is to be restored.  First, plans must accept some responsibility for
injuries caused when they breach their contracts to provide coverage.
Fortunately, the daunting risk of plan liability for coverage decisions that a
court or jury might deem erroneous in retrospect would be lessened if a plan
had embraced other elements of the contract-based strategy outlined here.
Thus, if contracts effectively conveyed the limited extent of the plans
commitment, perhaps by incorporating specific guidelines, there would be fewer
disputable decisions.  Moreover, if it were clear that the plan makes only
coverage, not treatment, decisions, plaintiffs would face substantial causation
issues if the patient failed to appeal the plan’s original decision or had the
option of spending other money to obtain the desired treatment.  Arbitration
clauses and provisions setting reasonable limits on liability would also help
plans stand behind their coverage determinations.
Presumptive vicarious legal liability for physician malpractice and for
other provider torts is an equally important key to legitimizing private financing
intermediaries in health care.141  As noted earlier, profit-oriented health plans
139. See Havinghurst, supra note 45.  See also Fuchs, supra note 131, at 1823-24 (predicting eventual
program of national health insurance in part because “employment-based health insurance has high
administrative costs but provides no advantages to society as a whole”).
140. See supra notes 41-44, 71-78 and accompanying text.
141. See generally Havighurst, supra note 42 (proposing vicarious liability as the default rule, subject
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were allowed to become responsible de facto for controlling the cost of care
while remaining generally immune from any legal responsibility for its quality.
This situation, which is now being ameliorated by curbing plans’ ability to
control costs, was so illogical as to induce wonder how the political/legal system
ever allowed it to develop.  In any event, it is within the power of individual
health plans to assume such liability voluntarily, thereby perhaps re-legitimizing
their efforts to resist the effects of moral hazard.142  The benefits of so doing
would include better alignment of the plan’s interests with providers’ concerns
about patient outcomes and quality, thus lessening plan/provider conflict and
facilitating more plan/provider integration than has generally been seen in the
health care revolution.  Vicarious liability would also induce plans to take
effective steps to improve the quality of care and to ensure that their physicians
honor their professional obligations to patients.143
For managed care to recover its legitimacy, health plans not only must
offer innovative products to consumers, but must also level with consumers
about precisely what they are selling, stressing its limitations as well as its
benefits.  To clarify what is being sold, for example, plan literature might give
consumers examples of the kinds of coverage limits the plan imposes, showing
how controlling guidelines operate to limit the plan’s obligation in particular
cases where good alternatives are available.  Such disclosures not only would
help to prepare enrollees for possible disappointments down the road, but
would also make the reasonableness of plan policies more apparent.  Plan
materials should also explain the trade-offs that have been made, showing how
the consumer benefits in lower premiums from the restrictions imposed on all
enrollees.144  Such candor would give consumers not only a clear idea that they
were purchasing something less than Cadillac-quality coverage, but also an
understanding of why it might make sense for them to do so.  With consumers
aware to this extent of the limits of their entitlements, it would be reasonable to
to a limited right of plans to delegate legal responsibility to subcontracting provider organizations).
142. Many physicians are currently facing burdensome new increases in the cost of their malpractice
coverage and may be receptive to new proposals to shift their liability to other shoulders.
143. See Havighurst, supra note 42, at 18-22 (arguing that vicarious liability would strengthen incen-
tives to maintain and improve quality and would promote, not undermine, physicians’ professionalism).
To see how plan/provider tensions would be reduced and professionalism reinforced, consider that a
plan facing vicarious liability for injuries caused by a physician’s failure to tell a patient all his treatment
options would have an additional reason (besides ensuring that its coverage decisions do not necessarily
determine actual treatment) to encourage physicians to disclose such alternatives—something plans
have been strongly criticized by physicians for discouraging.
144. Thus, a plan contract might include a provision like the following one:
Your Reasons for Accepting Limitations on Your Legal Rights.  You acknowledge that you have agreed
to the foregoing limitations on your entitlements under the Plan and to the foregoing rules governing
the interpretation and enforcement of your legal rights under the Plan—
(a) in order to ensure that the premiums collected from you and other Plan subscribers are disbursed
according to agreed-upon rules and
(b) in consideration of (1) the acceptance by other Plan subscribers of the same limitations and rules
and (2) the lower Plan premiums that these limitations and rules make possible.
Adapted from HAVIGHURST, HEALTH CARE CHOICES, supra note 3, at 188.
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expect both individual patients and the courts to accept the situation whenever
the coverage purchased proved less generous than they would wish.
However promising the foregoing scenario may seem, the prospects for
re-energizing health plans as revolutionary agents are, unfortunately, greatly
diminished by a number of circumstances.  An individual health plan embarking
on such radical innovations would clearly face prohibitive obstacles, including
providers’ hostility, regulators’ skepticism, litigation risks, and the high cost of
marketing new products to an entitlement-oriented public.  Indeed, the risks
and costs facing any first mover would be so great that meaningful change
probably cannot occur unless at least a major segment of the industry were
willing to redefine its mission and to take substantial collective actions in aid of
the cause, such as promoting new criteria for coverage, new guidelines
implementing those criteria, and accrediting and other measures designed to
validate new products.  Such revolutionary collective actions would be taken
only if industry participants became deeply convinced that their survival in the
business of financing health care required radical measures.  It is doubtful that
either individual managed care firms or the industry as a whole will ever




As this article has shown, Managed Care I proved itself a poor public
servant and was appropriately deposed in the counter-revolution it inspired.
Managed Care II apparently believes that, by cultivating a more benevolent
image than its predecessor, it will be able to hang onto power and ride out any
“perfect storm” that may be brewing and that its members can survive (despite
their relatively high costs) as private functionaries in a market increasingly
dominated and controlled by government.  Perhaps the industry is right that it
faces no emergent need finally to pick up the revolutionary banner and carry
forward the people’s cause.  (HMOs’ share prices have risen, against the trend,
so far in 2002.)  In any event, it has yet to produce statesmen with the vision and
leadership that would be needed to restart the health care revolution in the
name of exploited consumers.  To be sure, heroes may yet arise to revive the
revolutionary cause.  But most observers will probably conclude that, despite
the forceful logic supporting the neo-revolutionary agenda envisioned here (and
the vision of the original proponents of a market-oriented health care system),
it is unrealistic even to hope that consumers will eventually be empowered to
resist contributing their hard-earned dollars to support the American health
care enterprise—maintained as it is by, and for, a loose but powerful political
coalition comprising both a vast industry and the most affluent consumers of its
services.  In the probable correctness of this pessimistic conclusion lie some
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powerful lessons about the nature and limitations of American culture and
American institutions.
